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      ABSTRACT 
 
This thesis assesses the mechanisms by which biventricular and left ventricular pacing 
improves cardiac performance in patients with heart failure. We demonstrated for the first 
time that CRT results in an improvement in acute haemodynamic variables in heart failure 
patients with a narrow QRS duration that is comparable to the effects seen in heart failure 
patients with a broad QRS duration. In addition, we have shown that both biventricular 
(BIVP) and left ventricular pacing (LVP) significantly reduce external constraint to left 
ventricular filling, resulting in an increase in effective filling pressure. In heart failure 
patients with evidence of external constraint at rest, the acute haemodynamic benefits of both 
BIVP and LVP were principally due to the relief of external constraint and preload 
recruitment. However, in those patients with evidence of electrical dyssynchrony and a broad 
QRS duration, a significant haemodynamic benefit was derived from an enhancement in left 
ventricular contractility, presumably as a result of a reduction in left ventricular 
dyssynchrony. Patients with external constraint appear to derive a greater haemodynamic 
benefit from pacing due to the significant increase in stroke work that is associated with relief 
of external constraint and preload recruitment, in addition to the increase in stroke work 
derived from enhanced contractility due to a reduction in dyssynchrony. These findings will 
inform better patient selection for this therapy and also optimisation of pacing strategy in 
individual patients. 
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  CHAPTER 1 
     INTRODUCTION, LITERATURE REVIEW  
                                AND HYPOTHESES 
 
INTRODUCTION  
 
The worldwide prevalence of heart failure is increasing in part due to an ageing population. 
In the developed world, heart failure affects 1-2% of the general population (1), causing 
about 5% of all adult hospital admissions, and complicating a further 10-15% (2). It is 
estimated that 0.2% of the population are admitted to hospital with this condition each 
year. In the developed world, the major aetiological factors are ischaemic heart disease, 
hypertensive heart disease, idiopathic dilated cardiomyopathy and valvular heart disease. 
Patients with advanced heart failure (New York Heart Association (NYHA) class III-IV), 
have both a poor quality of life and a poor prognosis, with one third or more of patients 
dying within 6 months of diagnosis. The annual mortality amongst those surviving beyond 
six months is 10-15% (2). Death for patients with advanced heart failure is usually due to 
disease progression, or less commonly is sudden.  
 
There have been several therapeutic advances in the treatment of heart failure over recent 
years, with the use of beta-blockers, Angiotensin-converting enzyme (ACE) inhibitors, 
Angiotensin II-receptor blockers and mineralocorticoid receptor blockers. However the 
prognosis remains extremely poor and there is probably limited potential for therapeutic 
benefit from additional neurohumoral blockade. 
 
[1] 
 
For more than a decade several pacing modalities have been considered for patients with 
severe drug refractory heart failure, with varying results. More recently randomized 
clinical trials, observational studies and mechanistic studies have produced unequivocal 
support for the use of biventricular pacing in patients with NYHA III-IV refractory heart 
failure and evidence of ventricular conduction delay, most commonly seen as left bundle 
branch block on the electrocardiogram (ECG). These studies have consistently 
demonstrated an improvement in functional status, quality of life and exercise capacity in 
these patients. 
 
 
THE ROLE OF PACING IN HEART FAILURE AND THE DEVELOPMENT OF 
CARDIAC RESYNCHRONISATION THERAPY 
Hochleitner et al (3) first described the use of conventional sequential AV pacing for the 
treatment of congestive heart failure. The authors initially reported that right-sided dual 
chamber pacing with a short programmed atrio-ventricular (AV) interval was of benefit in 
patients with heart failure who had no conventional indication for pacing, and 
demonstrated a reduction in NYHA class, fall in cardiothoracic ratio on chest X-ray, and 
an increase in both systolic and diastolic blood pressure. The benefit was due to a reduction 
in pre-systolic mitral regurgitation, and hence an increase in left ventricular filling period. 
Pre-systolic mitral regurgitation is pronounced in those patients with prolongation of the 
AV interval and an elevated left ventricular end diastolic pressure. The acute 
haemodynamic results in this and other studies (4;5) were impressive, however subsequent 
studies assessing effects on haemodynamic variables, symptoms and clinical outcomes in 
heart failure did not demonstrate significant benefits (6-8). More recently the ‘Dual 
Chamber and VVI Implantable Defibrillator’ (DAVID) study (9) and the ‘Mode Selection’ 
(MOST) study(10) have suggested that right ventricular pacing per se may increase the 
[2] 
 
incidence of heart failure. It is believed that despite restoring AV synchrony, the attendant 
abnormal left ventricular electrical activation pattern results in dyssynchronous mechanical 
activity. 
 
Over the past decade an emerging body of evidence has shown the utility of both 
biventricular (BIVP) and left ventricular (LVP) pacing. The concept of biventricular 
stimulation was first tested clinically by Bakker et al, who demonstrated that BIVP 
improved functional capacity in patients with severe NYHA Class IV heart failure and left 
bundle branch block (LBBB) (11). The selection of patients with LBBB was based on the 
known adverse effects of LBBB, which results in late activation of the left ventricle 
(especially the left ventricular free wall) from the right ventricle via the septum, and 
subsequently a delay between the onset of left and right ventricular mechanical 
contraction. The presence of LBBB also results in abnormal ventricular septal motion, 
which in turn is related to interventricular dyssynchrony and an abnormal pressure 
differential between the right and left ventricle. The abnormal septal motion results in an 
increase in the left ventricular end systolic diameter and reduction in the left ventricular 
ejection fraction, cardiac output, mean arterial pressure and dP/dtMAX. LBBB is associated 
with more severe symptoms of heart failure and also a higher mortality in heart failure 
patients (12;13).  
 
 In the mid-1990’s there was considerable controversy as to whether the restoration of AV 
synchrony, sequential RV stimulation, or biventricular pacing might play a role in the 
treatment of patients with heart failure and conduction disturbances. The PATH-CHF study 
was designed to prospectively address these questions. This multicentre trial tested the 
hypothesis that acutely optimised, chronic atrial–synchronous biventricular stimulation in 
[3] 
 
patients with Class III-IV heart failure and conduction disturbances would lessen 
symptoms, increase exercise capacity, and improve quality of life. Results demonstrated a 
significant increase in functional capacity and quality of life, as well as a significant 
increase in anaerobic threshold and oxygen consumption at peak exercise (14). The initial 
clinical studies of long term biventricular pacing reported high peri-operative mortality 
figures, related to the early invasive epicardial lead placement procedure, involving 
thoracotomy under a general anaesthetic. Daubert et al, described the first transvenous 
approach for placing the left ventricular lead via the coronary sinus (15). 
 
Several long term studies, of differing study design, have reported impressive results with 
biventricular pacing in heart failure patients with a prolonged QRS duration (>130ms) who 
are severely symptomatic (NYHA III-IV) despite optimal medication. The InSync study 
(16) reported significant improvements in exercise capacity, NYHA class and quality of 
life; the Multisite Stimulation in Cardiomyopathy (MUSTIC) study (17) reported a 
significant improvement in exercise tolerance, NYHA score, peak oxygen uptake and 
cardiac ejection fraction; the Multicentre InSync Randomized Clinical Evaluation study 
(MIRACLE) (18) reported a significant improvement in exercise capacity and quality of 
life, and a 50% reduction in hospitalisation in the first 6 months. Core centre analysis of 
the echocardiography data from the MIRACLE study also provides evidence of reverse 
remodeling of the left ventricle.  
 
These studies were not powered to address mortality or morbidity as primary endpoints. 
However a meta-analysis of four studies (Contak CD, MUSTIC, MIRACLE, InSync ICD) 
with a total of 1634 patients reported a 51% reduction in progressive heart failure mortality 
from 3.5% to 1.7%, and a 21% reduction in hospitalization (19). The Comparison of 
[4] 
 
Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) study was a 
comparison of no pacing, biventricular pacing and biventricular pacing with ICD. It was 
halted prematurely because the ICD limb showed a 40% reduction in the combined end-
point of death from or hospitalisation for heart failure, compared with a 34% reduction in 
the biventricular limb (20). This resulted in biventricular pacing being granted a class IIA 
indication by ACC/AHA/NASPE.  
 
The results of CARE-HF have since been published. The trial was designed to evaluate the 
long-term effects of cardiac resynchronisation on the mortality and morbidity of patients 
with heart failure due to left ventricular systolic dysfunction with a QRS duration > 
120msec who were already receiving optimal medical therapy. A total of 813 patients were 
randomised to device therapy or control and followed up for a mean of 29.4 months. The 
trial reported a 37% reduction in combined all-cause mortality (death) or unplanned 
cardiovascular hospitalisation, and a 36% reduction in all-cause mortality (21). 
 
 
 
 
 
 
 
 
 
 
 
[5] 
 
TABLE 1.1. Major trials of Cardiac Resynchronisation Therapy in heart failure 
 
 MUSTIC INSYNC MIRACLE COMPANION CARE-HF 
Number n=131 n=103 n=453 n=1520 n=813 
 
Design 
Randomised 
Controlled 
Prospective 
Observational 
Double-Blind, 
Randomised 
Controlled 
Randomised 
Controlled 
Randomised 
Controlled 
 
Criteria 
NYHA III 
EF < 35% 
QRS > 150 
NYHA III/IV 
EF < 35% 
QRS > 150 
NYHA III/IV 
EF < 35% 
QRS > 130 
NYHA III/IV 
EF < 35% 
QRS > 120 
NYHA III/IV 
EF < 35% 
QRS > 120 
 
 
Outcome 
↑ QOL 
↑ EF 
↑ 6MWD 
↓ NYHA Class 
↑ Peak VO2 
max 
↑ QOL 
↑ EF 
↑ 6MWD 
↓ NYHA Class 
↑ Peak VO2 
max 
↑ QOL 
↑ EF 
↑ 6MWD 
↓ NYHA Class 
↑ Peak VO2 
max 
34% ↓ (CRT) 
40% ↓ (CRT-ICD) 
in death or 
hospitalisation due 
to CHF 
24% ↓ (CRT) 
36% ↓ (CRT-ICD) 
in death 
37% ↓ in 
death / 
unplanned 
hospitalisation 
for a CVS 
event 
39% ↓ in 
unplanned 
hospitalisation 
for a CVS 
event 
 
 
 
[6] 
 
MECHANISMS OF BENEFIT IN RESPONSE TO CARDIAC 
RESYNCHRONISATION THERAPY (CRT) 
 
Several mechanisms are thought to be responsible for the benefit seen in response to CRT 
in patients with heart failure.  
 
ELECTRICAL AND MECHANICAL RESYNCHRONISATION 
Dilatation of the left ventricle and associated fibrosis frequently induces intracardiac conduction 
delays resulting in dyssynchronous left ventricular motion. This often manifests as LBBB on the 
surface ECG. Biventricular pacing is currently advocated for patients with NYHA III and IV 
Class symptoms despite optimal medical therapy who have prolonged QRS durations (>120 ms).  
The latter is based on the original rationale that biventricular pacing acts via an improvement in 
cardiac ‘electrical synchrony’, hence the frequently used term “resynchronisation therapy”. The 
phenomenon of dyssynchrony is a consequence of a progressive, global, or focal disorder of the 
myocardium, leading to heterogeneous propagation of cardiac electrical and mechanical activity. 
There are at least three components to dyssynchrony that may impair cardiac function by affecting 
the systolic and diastolic properties of the heart. 
(a) Prolongation of the atrio-ventricular (AV) conduction time leading to AV dyssynchrony is 
common in patients with heart failure (22). The delay in the onset of ventricular systole 
following passive and active ventricular filling gives rise to pre-systolic mitral regurgitation 
(23). This results in a lower left ventricular preload, higher pulmonary capillary wedge 
pressure, and a decreased cardiac output. 
(b) Interventricular dyssynchrony occurs when the left and right ventricles fail to contract 
simultaneously. This is usually as a result of right or left bundle branch block, and often 
leads to septal contraction which is out of phase with one or other ventricular free wall. 
[7] 
 
(c) Intraventricular dyssynchrony occurs when there is marked heterogeneity in the timing of 
mechanical events between different segments of the left ventricle. As a consequence the 
ventricle expends a great deal of energy changing its shape but not ejecting blood. This 
dyssynchrony commonly extends to the papillary muscles resulting in mitral regurgitation. 
Although partly due to electrical dyssynchrony, other factors appear to contribute to 
mechanical dyssynchrony (24;25).  
 
There is increasing evidence that there is only a weak correlation between electrical (QRS 
duration) and mechanical dyssynchrony and the benefit of CRT therapy (17;18;25;26). A 
substantial proportion of patients with a prolonged QRS duration (up to a third) do not exhibit 
inter- or intraventricular dyssynchrony (26;27), which may at least partly explain why up to a third 
of heart failure patients with prolonged QRS duration derive no benefit. Furthermore, 
dyssynchrony is common even in heart failure patients with narrow QRS complexes (28), a group 
currently excluded from biventricular pacing treatment guidelines. 
 
There is as yet no gold standard technique for quantifying intraventricular mechanical 
dyssynchrony. The QRS width on surface ECG is a simple method often used as a 
surrogate for mechanical dyssynchrony, but the sensitivity for predicting the benefit from 
CRT is low  (29;30). MRI can also detect areas of dyssynchrony, but this technique is 
expensive and cannot be repeated for follow-up after device implantation. 
Echocardiographic tools are the most useful for the assessment of dyssynchrony. Studies 
have shown that measuring time to peak tissue velocity (Ts) from myocardial velocity 
curves using Tissue Doppler Imaging (TDI) is useful for quantitative assessment of 
systolic dyssynchrony. In particular, the dyssynchrony index (Ts-SD), or standard 
deviation of Ts in a 12-segment model, was a powerful predictor of LV reverse remodeling 
[8] 
 
after CRT therapy (31). Tissue Synchronisation Imaging (TSI) is a technological 
advancement in the assessment of systolic dyssynchrony by transforming the Ts into 
different colour-coding. It has the advantage of providing a visual aid for quick 
identification or regional delay within the LV wall. Yu et al have shown a good correlation 
between Ts or Ts-SD derived from both TDI and TSI (31). However, recent evidence 
suggests that conventional measures of dyssynchrony have high inter-observer variability 
(32) and may also underestimate the magnitude of dyssynchrony because they ignore radial 
dyssynchrony. Current dyssynchrony analysis is based on echo-Doppler methods which 
are largely derived from longitudinal motion data. This choice of orientation is mainly 
based on practical grounds given the available echocardiographic windows for transducer 
positioning. However, due to epicardial and subendocardial fiber orientation, cardiac 
contraction is principally radial. Helm and colleagues have demonstrated in a failing heart 
that dyssynchrony assessed by longitudinal motion is much less sensitive (33), suggesting 
that longitudinal motion data may not provide the most accurate and comprehensive means 
of assessing left ventricular dyssynchrony. 
 
REDUCTION IN MITRAL REGURGITATION 
Three mechanisms are responsible for mitral regurgitation in congestive heart failure. 
(a) As mentioned earlier, prolongation of the AV interval generates pre-systolic mitral 
regurgitation by generating a diastolic ventricular-atrial pressure gradient. This is 
because the end of atrial contraction occurs much earlier than the onset of the rise 
in intraventricular pressure. Because of the altered geometry within a dilated left 
ventricle, appropriate mitral or tricuspid closure is probably not complete until the 
start of ventricular contraction. This can lead to early systolic or late-diastolic 
[9] 
 
mitral regurgitation. Brecker et al (4) showed that pacing with short AV intervals 
can reduce or abolish diastolic mitral regurgitation. 
(b) ‘Functional’ systolic mitral regurgitation in dilated cardiomyopathy is a result of 
ventricular dilatation and increased chamber sphericity. The resultant increase in 
distance between the papillary muscles to the enlarged mitral annulus, as well as to 
each other, restricts leaflet motion and increases the force needed for effective 
valve closure (34-36). The mitral valve closing force is determined by the systolic 
left ventricle-left atrium pressure difference (or transmitral pressure gradient). 
Increasing this pressure gradient can decrease the effective regurgitant orifice area 
(EROA). Studies have shown that CRT (by re-coordinating LV contraction) acutely 
increases the maximal rate of LV systolic pressure rise (dP/dtMAX ) and thus the 
transmitral pressure gradient (37;38). Breithardt et al (39) studied 24 consecutive 
patients with severely impaired LV function, LBBB, and functional mitral 
regurgitation. CRT acutely reduced the severity of mitral regurgitation by 
decreasing the effective regurgitant orifice area (EROA). This effect was directly 
related to an improvement in LV systolic function causing an accelerated rise in the 
transmitral pressure gradient (TMPG). The acute effect was independent of 
geometrical changes (reverse remodelling). 
(c) Kanzaki et al (40) have described a further mechanism for the reduction in mitral 
regurgitation seen with CRT. Mitral regurgitation in patients with a LBBB relates 
to an altered systolic balance of forces acting on the papillary muscles due to 
uncoordinated regional LV contraction. Utilising strain imaging on 
echocardiography, they demonstrated a delay in peak strain at the mid-lateral 
segment adjacent to the anterolateral papillary muscle (implying tethering of the 
mitral leaflet), which was improved immediately after CRT. 
[10] 
 
FIGURE 1.1. Mechanisms of Improvement in Mitral Regurgitation 
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LEFT VENTRICULAR REVERSE REMODELLING 
Biventricular pacing has been shown to have a beneficial effect on left ventricular 
remodelling. Enhanced ventricular ejection efficiency resulting from coordinate 
contraction, a reduction in mitral regurgitation, and a reduction in 
sympathetic/parasympathetic imbalance may contribute to chronically unload both 
ventricles and initiate reverse remodelling. 
(a) Effects on left ventricular chamber geometry and dimensions 
In a non-randomised study, Yu et al evaluated 25 NYHA class III-IV patients with an 
ejection fraction <40% and a QRS duration >140ms, who received biventricular 
pacing. Continued pacing at 3 months in these patients resulted in significant 
improvements in ejection fraction, left ventricular volumes, dP/dtMAX, myocardial 
performance index and the degree of mitral regurgitation, as well as a decrease in the 
[11] 
 
sphericity index. Withholding pacing for a 4 week period resulted in a progressive, but 
not immediate, loss of effect. It was concluded that the improvement in left ventricular 
mechanical dyssynchrony was the mechanism for this (41). Data from several 
randomised trials consistently shows that CRT is able to induce reverse remodeling in 
the vast majority of patients. Stellbrink et al analysed 25 patients included in the 
PATH-CHF trial, focusing on changes in LV volumes after CRT. Left ventricular end 
diastolic (LVEDD) and end-systolic dimensions (LVEDS) were significantly reduced 
after 6 months, as were LV volumes (42). These findings are supported by data from 
the MIRACLE, CONTAK-CD, Vigor-CHF and INSYNC-ICD trials. 
(b) Effects on neurohumoral pathways 
      Sympathetic activity is increased in patients with congestive heart failure, as  
      demonstrated by elevated levels of circulating noradrenaline and an increase in  
      adrenergic nerve outflow, as measured with microneurography. The cause of this    
      increase is thought to be in part due to abnormal baroreflex control of adrenergic flow  
      from the central nervous system. Although initially compensatory, chronic adrenergic  
      activation promotes disease progression. Saxon et al recently reported no  
      significant alteration in noradrenalin levels during three months of biventricular  
      pacing (43). However, Hamdan and colleagues compared BV pacing with single-site  
      pacing in patients with LV dysfunction. Results demonstrated that both acute BV and  
      LV pacing reduced sympathetic activity compared with RV pacing regardless of the  
      QRS duration (44), and Braun et al demonstrated significant decreases in noradrenalin  
      and NT-proBNP after short-term CRT in patients with congestive heart failure and  
      conduction delay, although this effect was attenuated after 24 months of long-term  
      follow-up (45). 
 
[12] 
 
IMPROVEMENT IN LEFT VENTRICULAR FILLING 
Cardiac resynchronisation therapy may improve the diastolic filling time of the left 
ventricle in several ways: 
1. Reducing pre-systolic mitral regurgitation 
2. Improving ventricular synchrony during active relaxation, biventricular pacing 
might theoretically improve diastolic filling, although two studies have reported no 
improvement in Tau (25;38) 
3. Reducing external constraint to left ventricular filling 
 
EXTERNAL CONSTRAINT AND DIASTOLIC VENTRICULAR INTERACTION 
In 1895, Otto Frank (46) observed that as the left ventricle was stretched its force of 
contraction increased. Subsequently, Starling (47) reported that the force of ventricular 
contraction increased with increasing atrial pressure (the Starling relation), and later 
proposed a descending limb of the Starling curve (i.e. indicating a reduction in myocardial 
contraction at very high filling pressures). In an editorial in 1965, Katz (48) concluded that 
a descending limb of the Starling curve did indeed exist in severe heart failure, and had 
serious prognostic consequences. Data that have emerged since that time suggest that this 
descending limb relates to DVI in heart failure. Dupuis et al (49) reported a sustained 
haemodynamic benefit in some patients with severe chronic heart failure from a 72 h 
infusion of nitroglycerine. Among patients whose stroke volume increased, a tendency 
towards an increased LVEDV was noted, despite a fall in pulmonary capillary wedge 
pressure. Among patients in whom the stroke volume fell, however, LVEDV generally 
dropped. 
 
Atherton et al (50) and Dauterman et al (51) have shown that in many heart failure patients the 
filling of the left ventricle may be impeded by external constraint from the raised pressure in the 
[13] 
 
stretched pericardium (pericardial constraint) and from the right ventricle via the interventricular 
septum (diastolic ventricular interaction). In these circumstances reducing central blood volume 
may acutely increase left ventricular diastolic volume despite reducing LV diastolic pressure. This 
is because the reduction in external constraint from the right ventricle and pericardium increases 
the true left ventricular distending pressure. LV pacing induces a phase shift such that LV 
contraction and filling both occur before they do in the RV (52-54). Because pericardial stretch 
(and therefore pericardial pressure) depends on total cardiac volume, a smaller RV volume during 
LV filling would result in less constraint to LV filling, a greater LV end-diastolic volume, and (by 
the Frank Starling mechanism) a greater LV stroke work. Bleasdale and colleagues (55) recently 
showed that LV pacing reduced this external constraint, effectively recruiting preload, presumably 
by causing the LV to fill relatively earlier, and therefore reducing the external constraint acting on 
the left ventricle at mid-diastole. 
 
PATIENT SELECTION FOR CARDIAC RESYNCHRONISATION THERAPY 
The present guidelines for patient selection for CRT are based largely on the entry criteria 
for the aforementioned larger clinical trials. The present criteria, as published by the 
National Institute for Clinical Excellence (NICE, 2003) are: drug refractory symptoms, 
NYHA III-IV, ejection fraction <35%, QRS duration >120ms, non-reversible cause, left 
ventricular end diastolic dimension >6cm. Despite the positive results of CRT trials, more 
than a third of patients receiving CRT therapy are non-responders. As mentioned earlier, 
echocardiographic markers of mechanical dyssynchrony show considerable variation in 
patients with broad QRS duration, and marked mechanical dyssynchrony may be present in 
heart failure patients with narrow QRS duration (25;28).  Biventricular pacing (which 
reduces QRS duration) reduces indices of mechanical dyssynchrony, but curiously, despite 
increasing QRS duration, LV pacing also reduces mechanical dyssynchrony (25). 
[14] 
 
Furthermore, the BELIEVE study reported comparable clinical benefit from left 
ventricular and biventricular pacing (56).  Nevertheless, several studies, using a variety of 
techniques have shown that biventricular pacing produces the greatest echocardiographic, 
haemodynamic and clinical benefit in those patients with the greatest mechanical 
dyssynchrony at baseline and reductions in dyssynchrony with pacing also predict these 
benefits (41;57;58). Some patients with narrow QRS complexes (who do not fulfill current 
criteria) may benefit.  A better understanding of the mechanisms of benefit of biventricular 
and left ventricular pacing may lead to improved patient selection and optimisation of 
pacing strategy in individual patients. 
 
TABLE 1.2. Current Guidelines for CRT Therapy 
 
NICE GUIDELINES 
 
•Drug-refractory, NYHA Class III-IV 
 
•LVEF < 35% 
 
•Sinus rhythm 
 
•QRS Duration >150ms OR QRS >120ms and   
  mechanical dyssynchrony on echocardiography 
 
•LVEDD > 6cm 
 
•Non-reversible cause 
 
 
 
ACC/AHA/NASPE 
GUIDELINES –  
CLASS IIA INDICATION 
 
•Drug-refractory, NYHA Class III-IV 
 
•Dilated or ischaemic  cardiomyopathy 
 
•QRS duration >130ms 
 
•LVEDD ≥ 55mm 
 
•LVEF ≤ 35% 
[15] 
 
SPECIFIC QUESTIONS TO BE ANSWERED 
Aside from the haemodynamic benefits from cardiac resynchronisation therapy, many 
questions still remain: 
(a) CRT in Patients with Heart Failure who have a Narrow QRS Duration 
Previous small studies in patients with a narrow QRS duration have focused on clinical 
and echocardiographic end-points. Although these have shown a benefit from CRT 
based on clinical and echocardiographic parameters, these studies included QRS 
durations of < 150ms as ‘narrow’ and were limited to patients with evidence of 
dyssynchrony on echocardiography. In a study by Achilli et al (59), the authors report 
the efficacy of CRT in such a group of patients, with 14 of the 56 patients having a 
QRS duration of < 120ms. These findings were supported by those of Gasparini and 
colleagues (60), who reported an improvement in clinical and echocardiographic 
parameters in patients with a narrow QRS (13 of whom had a QRS < 120ms).  The 
studies by Bleeker et al (61) and Yu et al (62) included 33 and 51 patients respectively 
with a QRS < 120ms. They showed an improvement in clinical parameters and 
evidence of left ventricular reverse remodeling, but in addition the study by Yu et al 
showed an improvement in exercise capacity as evidenced by an improvement in 
maximal metabolic equivalent achieved on treadmill testing (62). 
     However, a recent much larger study (RETHINQ) in an ICD population who all met   
     conventional dyssynchrony criteria for CRT but had QRS duration <130msec did not  
     report a significant improvement in exercise capacity or evidence of reverse  
     remodeling (63). 
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(b) Biventricular (BIVP) Versus Left Ventricular Pacing (LVP) 
Despite marked differences in ventricular pacing-induced QRS widths, BIVP and LVP 
pacing have proved equally effective in enhancing cardiac function in failing human 
hearts with LV dyssynchrony (37;38;64;65). This similar haemodynamic improvement 
despite striking differences in QRS duration supports the concept that mechanical 
rather than electrical resynchronisation is likely to be the most important phenomenon 
in achieving benefit from pacing therapy.  
 
In order to clarify the respective mechanisms of BIVP and LVP responsible for similar 
haemodynamic improvement despite differing electrical activation, Bordachar et al 
(38;66) conducted an acute echocardiographic study in 33 severe heart failure patients 
to compare haemodynamic and dyssynchrony parameters during the two modes of 
pacing. Results showed that although LVP and BIVP produced similar haemodynamic 
improvements, LVP was associated with a substantial reduction of intra-LV 
dyssynchrony. However, it was also associated with a shortened LV filling time and a 
longer aortic pre-ejection delay (time to onset of aortic flow on continuous wave 
Doppler), as well as worsened interventricular dyssynchrony. However, to date only 
intraventricular and not interventricular dyssynchrony has been associated with an 
adverse outcome in patients with heart failure (38;67;68). 
 As mentioned earlier, one of the mechanisms of improvement with CRT in heart 
failure is a reduction in external constraint. LVP induces a phase shift such that LV 
contraction and filling both occur before they do in the RV. Whether BIVP may 
similarly reduce external constraint is uncertain. Because it would be expected to 
produce a lesser phase shift in the time of ventricular filling, the benefit may not be as 
great. 
[17] 
 
HYPOTHESES 
(1) The acute haemodynamic benefits of LVP and BIVP are similar in patients with 
heart failure and narrow QRS complexes to those seen in patients with broad QRS 
complexes. 
(2) The acute haemodynamic benefits of LVP are principally due to a reduction in 
diastolic ventricular interaction. 
(3) BIVP reduces diastolic ventricular interaction (in those in whom it is present) in 
patients with broad QRS complexes but not in those with narrow QRS complexes. 
 
 
AIMS OF THE STUDY 
Despite the wealth of data available on the effects of Cardiac Resynchronisation Therapy 
in congestive heart failure, a number of important questions remain. This study will assess 
the mechanisms by which biventricular and left ventricular pacing improves cardiac 
performance in patients with heart failure. It will assess the relative contributions of 
reduced diastolic ventricular interaction, enhanced contractility, and a reduction in mitral 
regurgitation to the acute benefit of each pacing modality in heart failure patients with both 
narrow and broad QRS complexes. The findings will better inform patient selection and 
also allow optimisation of pacing strategy in individual patients according to underlying 
physiology. 
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  CHAPTER 2 
            METHODOLOGY AND STUDY PROTOCOL 
 
ASSESSMENT OF CARDIAC PERFORMANCE BY PRESSURE-VOLUME 
LOOPS 
 
Assessment of left ventricular systolic and diastolic pump properties is fundamental to 
advancing our understanding of cardiac pathophysiology and assessing the effects of both 
pharmacologic and non-pharmacologic therapies, particularly in heart failure. The use of 
the ventricular pressure-volume relation began as far back as 1895, when Otto Frank first 
described the relationship between filling volume and strength of myocardial contraction 
(46). However, the technique proceeded at a slow pace thereafter due to difficulties with 
assessing ventricular volumes in the intact human or animal heart(69;70).  
 
With the development of the isolated blood-perfused canine heart model there was a 
resurgence of activity in the 1970’s and 1980’s (71;72). This led to a series of pivotal 
studies detailing the use of end-systolic and end-diastolic pressure-volume relations 
(ESPVR and EDPVR) as a measure of intrinsic myocardial pump properties (72;73). 
Further studies have described the characteristics of these relationships in detail, and have 
validated techniques for measuring ventricular volume (74), allowing these techniques to 
be applied to basic and clinical research. In addition, the physiological significance of the 
ESPVR and EDPVR has been demonstrated by their correlation with myocardial energy 
demand (75;76). Because the technique is applicable to the hearts of all species, pressure-
volume analysis has become a standard technique in studies of both humans and animals of 
all sizes.  
[19] 
 
When assessing cardiac performance, it is important to remember that two distinct 
properties of cardiac function, that are intimately interrelated, are being assessed. One is 
assessment of the properties of the ventricle as a haemodynamic pump (both systolic and 
diastolic), and the second intrinsic properties of the myocardium itself. However, pump 
function is dependent on intrinsic myocardial properties such as muscle mass, myocardial 
architecture, and chamber geometry. The pressure-volume relation is used mainly to assess 
ventricular pump function, but some parameters derived from this relation yield 
information about intrinsic myocardial properties.  
 
THE CONDUCTANCE CATHETER TECHNIQUE 
The conductance catheter technique developed by Baan et al (74;77) enables continuous 
real-time measurements of left ventricular (LV) volume and pressure. The method has 
been described extensively as a method of assessment of global systolic and diastolic 
ventricular function. The conductance methodology is based on the measurement of 
electrical conductance of the blood within the left ventricle. The catheter contains multiple 
electrodes which when positioned along the long axis of the left ventricle generate an intra-
cavitary electric field (utilising the two most distal and two most proximal electrodes) and 
sense the resulting voltage gradients. The remaining electrodes measure segmental 
conductance signals which represent the instantaneous volumes or corresponding slices of 
the left ventricle (Figure 2.1).  
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FIGURE 2.1. Positioning of conductance catheter in the left ventricle 
 
 
 
The measured conductance (applied current divided by the measured voltage gradient) is 
subsequently converted to an absolute volume by taking into account the specific 
conductivity of the blood and the electrode spacing. Parallel conductance (the offset in 
volume due to structures surrounding the left ventricular cavity i.e. the right ventricle) is 
determined by the hypertonic saline dilution method (74;78), and subsequently subtracted.  
 
The conductance-derived stroke volume and cardiac output are generally an 
underestimation of actual stroke volume and cardiac output due to electrical field 
inhomogeneity and because the segments do not fully cover the LV long axis.  
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This is corrected by using a slope factor (α) which is calculated by comparing the catheter-
derived cardiac output, and the cardiac output determined using the Fick equation: 
 
 
    ___________O2 consumption                      ____________ 
      Fick cardiac output =  
((arterial sats) – (mixed venous sats)) x Hb x 1.34 x 10 
  
           
 
 
Hence: 
 
 
 
            Slope factor (α)      = Catheter derived cardiac output / Fick cardiac output 
 
 
 
 
The catheter also contains a solid-state, high-fidelity pressure sensor to measure 
instantaneous left ventricular pressure. Currently most pressure-volume studies performed 
in humans use combined pressure-conductance catheters. These catheters are typically 7-
French, over-the-wire, pigtail catheters which are connected to a dedicated patients module 
to allow generation of an electric field, measurement of resting voltages, and the 
acquisition of pressure, volume and ECG signals.  
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GENERATED PRESSURE-VOLUME SIGNALS, LOOPS AND RELATIONS 
When positioned in the long-axis of the LV, the combined pressure-conductance catheter 
yields real-time segmental volume signals and an LV pressure signal with a temporal 
resolution of 4ms. The total LV volume is then calculated as the instantaneous sum of the 
segmental volumes. In order to assess ventricular pump function, pressure and volume 
signals are combined to construct a pressure volume loop, with each loop representing one 
cardiac cycle. The distinct cardiac phases are shown in Figure 2.2. Important parameters of 
both systolic and diastolic ventricular function can be determined either directly from the 
pressure-volume loop, or from the pressure and volume time curves and their derivatives.   
 
FIGURE 2.2. A representative pressure-volume loop. Cardiac phases and timing of 
aortic and mitral valve opening and closure are depicted 
 
A. Mitral valve closure; B. Aortic valve opening;  
B. C. Aortic valve closure; D. Mitral valve opening 
[23] 
 
Many of these parameters are to a large extent load-dependent, and in order to overcome 
this problem it is possible to construct pressure-volume relations which are much less load-
dependent. This requires the acquisition of a series of pressure-volume loops over a range 
of loading conditions, which must be achieved by an intervention that has minimal effect 
on intrinsic myocardial function. This can be achieved utilising inferior vena caval balloon 
occlusion, which results in a rapid, purely mechanical, reduction in preload which is easily 
and rapidly reversible. A typical example is shown in Figure 2.3.  
 
FIGURE 2.3. Pressure-volume loops acquired during preload reduction by means of 
inferior vena caval occlusion.  
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ASSESSMENT OF SYSTOLIC FUNCTION 
INDICES OF CARDIAC CONTRACTILE FUNCTION 
Important parameters characterising left ventricular contractile function can be determined 
directly from the pressure-volume loop without the need for construction of curves or 
relations between variables. These include stroke volume, cardiac output, stroke work, and 
dP/dtMAX.  An important limitation of all of these indices is their relative load-dependence. 
 
END-SYSTOLIC PRESSURE VOLUME RELATION (ESPVR) 
As demonstrated by Figure 2.3, the ESPVR is constructed by connecting the pressure-
volume points of each loop acquired during IVC occlusion. The ESPVR characterises the 
properties of the left ventricle at the point of maximal activation, and was initially thought 
to be a reasonably linear relation with a slope (EES – end-systolic elastance) and an 
intercept on the volume axis (VO). Inotropic agents that increase contractile state have been 
shown to increase EES with relatively little change in VO (i.e. an increase in the slope of the 
ESPVR), while negative inotropes decrease the EES with little effect on VO (79). Similarly, 
increases in heart rate result in an increase in EES via the force-frequency relationship. 
 
 In the latter studies the end-systolic pressure volume relation (ESPVR) was determined 
using the single-beat method (EES) adopted from Takeuchi et al (80). There are several 
limitations to the assessment of ESPVR. Firstly, the ESPVR has been shown to be 
influenced by afterload impedance, but this effect is relatively small and can generally be 
ignored in most in-vivo studies as afterload conditions do not vary over very wide ranges. 
Secondly, the ESPVR is in reality non-linear over the entire range of pressures, and 
becomes convex in situations of enhanced inotropic state and concave with depressed 
inotropic state (81). Thirdly, ESPVR is dependent on muscle mass and geometry, but this 
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effect can be ignored in acute studies which assess an intervention and these variables are 
fixed over the various interventions. 
 
PRELOAD RECRUITABLE STROKE WORK RELATION (PRSWR) 
The PRSW relation is generated by plotting stroke work against end-diastolic volume 
during preload-reduction, resulting in a slope (Mw) and an axis intercept value (which is 
represented by the theoretical unstressed volume of the heart at a point when stroke work is 
equal to zero) (Figure 2.4). The theoretical unstressed volume of the heart is calculated 
using the equation LVEDV multiplied by a constant value k=0.72 for hearts with an end 
diastolic volume ≥ 95.7ml (82). This relation has many advantages over assessment of the 
ESPVR, including linearity, afterload independence, heart rate independence, and an 
independence of heart size, and presents the gold-standard for assessing changes in 
myocardial contractile performance. 
 
FIGURE 2.4. Preload recruitable stroke work relation from a study patient during no 
pacing (OFF), biventricular pacing (BIVP) and left ventricular pacing (LVP) 
 
ASSESSMENT OF DIASTOLIC FUNCTION 
[26] 
 
INDICES OF ACTIVE RELAXATION AND LEFT VENTRICULAR FILLING 
Important parameters characterising left ventricular relaxation and filling can be 
determined directly from the pressure data, although these too are limited by their 
dependence on load.  These include dP/dtMIN (minimal rate of pressure change) and Tau 
(τ), the relaxation time constant.  
 
END DIASTOLIC PRESSURE VOLUME RELATION (EDPVR) 
The EDPVR is intrinsically non-linear due to different types of structural fibres being 
stretched in different pressure-volume ranges (83). In the low pressure-volume range 
compliant elastin fibres and myocytes with sarcomeric titin molecules account for diastolic 
stiffness (84), resulting in only a small increase in pressure for any given increase in 
volume. As volume is increased further, pressure rises more steeply as the slack lengths of 
collagen fibres and titin molecules are exceeded and further stretch is strongly resisted by 
these stiffer elements. Therefore chamber stiffness increases as end diastolic pressure or 
volume is increased. Nonlinear regression analysis may be applied to EDPVR data in order 
to develop simple indices of left ventricular chamber stiffness or compliance. Shifts of the 
EDPVR may reflect changes in myocardial properties (fibrosis, ischaemia or oedema) or 
pathological remodelling (with hypertrophy and chamber dilatation in heart failure), but 
take into account the net effects of changes in myocardial properties, chamber structural 
properties, and changes in the extracellular matrix.  
 
The slope of the EDPVR can be determined using a single-beat method to calculate the 
EED (a measure of end diastolic chamber stiffness which is derived from a linear fit of the 
filling phase trajectory of the pressure-volume loop). Similarly the end-diastolic stiffness 
[27] 
 
constant KVED can be derived by fitting an exponential curve to the diastolic trajectory of 
the pressure-volume loop as previously described by Steendijk et al (85). 
 
ASSESSMENT OF EXTERNAL CONSTRAINT TO LV FILLING  
External constraint (EC) to LV filling can be determined using a modified static 
equilibrium technique whereby external constraint is quantified as the difference in 
LVEDP before and after removal of the pericardium while a constant LVEDV is 
maintained. This technique can only be used when the chest is open. However, a 
modification can be applied by continuous measurement of LV pressure and volume 
during occlusion of the IVC to acutely reduce RV volume and pressure (51). This acute 
reduction in RV volume removes external constraint to LV filling from the RV and 
pericardium. During this intervention, LVEDP is progressively reduced over several beats. 
For each beat, the relation between LVEDP and LVEDV is assessed. In the absence of 
external constraint, IVC occlusion gradually reduces both LVEDP and LVEDV, with the 
values progressing downward and leftward along a single end-diastolic pressure-volume 
relation. In contrast, in severe heart failure, when marked external constraint is present, 
LVEDV initially (for a few beats) increases as LVEDP falls. Only after the external 
constraint has been removed do the pressure-volume values move down and to the left 
(Figure 2.5). The magnitude of external constraint is then calculated as shown in Figure 
2.6. 
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FIGURE 2.5. Response to inferior vena caval occlusion in a patient with congestive 
cardiac failure and significant external constraint (left panel) and a healthy control 
(right panel) 
 
 
FIGURE 2.6. Quantification of external constraint after inferior vena caval occlusion 
in a patient with congestive cardiac failure and significant external constraint 
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ASSESSMENT OF LEFT VENTRICULAR SUCTION  
 
 PRESSURE-VOLUME LOOP ANALYSIS 
The term ‘suction filling’ has been defined by Katz as the phenomenon whereby the left 
ventricle relaxes faster than it can fill (86), resulting in  a fall in pressure as the left 
ventricle enlarges. Suction filling is therefore the period of filling which occurs during the 
period of pressure decline to minimum pressure after the mitral valve has opened. This can 
be calculated from the pressure-volume loop by the following equations: 
 
 
Vsuction = V@Pmin – Vmin 
 
% Suction filling =     Vsuction____  
                           Stroke volume 
 
 
 
 
where Vsuction is the total volume of filling occurring between mitral valve opening 
(Vmin or minimum volume) and the point of minimum pressure (V@Pmin or volume at 
minimum pressure), and the percentage of suction filling is equal to Vsuction divided by 
stroke volume (see Figure 2.7). 
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 FIGURE 2.7. Representative pressure-volume loop from a patient with congestive 
heart failure 
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ECHOCARDIOGRAPHY 
Echocardiography was used to compare time intervals related to left ventricular filling with 
those obtained from the pressure volume loops. These recordings were obtained with the 
patients lying in a supine position at rest at identical heart rates to those during the pressure 
volume loop studies. Transmitral flow was recorded in the standard apical four-chamber 
view with the sample volume positioned between the tips of the mitral leaflets. The 
isovolaemic relaxation time (IVRT) was derived by subtracting the time interval from Peak 
R-Wave of the ECG to mitral valve opening (onset of E wave) from the time interval from 
Peak R-wave to aortic valve closure. This method incorporating the use of the ECG 
complex eliminates the possibility of measurement error caused by valve artifact when 
measuring small time durations using continuous or pulsed wave Doppler imaging. The 
time interval from the Peak R-Wave of the ECG to the peak of the E wave on transmitral 
flow (T-Peak E) was also measured. The IVRT and T-Peak E time intervals derived from 
echocardiography was compared with the IVRT and T-Pmin derived from the pressure 
volume loops. 
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PATIENT RECRUITMENT 
Patients were recruited from the heart failure clinics at the Queen Elizabeth Hospital 
(Birmingham), Good Hope Hospital (Sutton Coldfield), Sandwell Hospital (West 
Bromwich), and St Peter’s Hospital (Chertsey). Inclusion and exclusion criteria are 
detailed below: 
 
Inclusion Criteria 
Congestive heart failure due to ischaemic or dilated cardiomyopathy  
Sinus rhythm 
NYHA III or IV breathlessness despite optimal tolerated medical therapy  
Exclusion Criteria 
Atrial fibrillation 
Structural valve disease 
Previous cardiac surgery 
Structural pericardial disease  
 
Patient Groups 
(1) Narrow QRS duration with no evidence of inter or intraventricular dyssynchrony 
(2) Broad QRS duration (unselected for dyssynchrony) 
(3) Control group with structurally normal heart undergoing EPS and ablation 
 
Details of patient recruitment are detailed in the following flow charts: 
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NARROW QRS PATIENT GROUP 
 
 
Assessed for eligibility (n=94)  
 
Excluded (n=52) 
♦   Not meeting inclusion criteria (n=49) 
♦   Declined to participate (n=2)  
 
 
Failed Implantation (n=2) 
Proceeded to Implant of CRT device (n=42) 
 
 
 
 
 
Unable to collect data at time of L + RHC (n=9)
Underwent Left and Right Heart 
Catheterisation for Haemodynamic 
Assessment (n=40) 
Discontinued intervention (give reasons)
 
 
 
 
 
 
Analysed (n=31)  
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BROAD QRS PATIENT GROUP 
 
 
Patients undergoing Implant of CRT device 
(n=30)  
 
 
 
 
 
 
Unable to collect data at time of L + RHC (n=5)
Underwent Left and Right Heart 
Catheterisation for Haemodynamic 
Assessment (n=30) 
Discontinued intervention (give reasons)
 
 
 
 
 
 
Data excluded from analysis due to poor 
quality signal (n=2) 
 
 
 
 
Analysed (n=23) 
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STATISTICAL ANALYSIS 
All data are expressed as the mean value ± SD. For continuous variables that were not 
normally distributed, the median and range are expressed. 
 
A repeated measure ANOVA was used to assess changes for paired samples if the data was 
normally distributed based on a Kolmogorov-Smirnov test. For data that was not normally 
distributed, a Kruskal-Wallis test was used and medians reported.  If the repeated measure 
ANOVA was statistically significant then pairwise comparisons were performed.  
 
For comparison of data between patients groups (independent samples) a non-parametric 
Mann-Whitney test was performed. 
 
Statistical significance was assumed at p<0.05. 
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CHAPTER 3  
 
           ACUTE HAEMODYNAMIC EFFECTS OF CARDIAC   
            RESYNCHRONISATION THERAPY ON SYSTOLIC  
                              AND DIASTOLIC FUNCTION 
 
INTRODUCTION 
 
The effects of cardiac resynchronization therapy (CRT) in patients with heart failure and a 
QRS duration ≥ 120ms are well established (20;21). In the Cardiac Resynchronization 
Therapy Heart Failure (CARE-HF) study, CRT was associated with a 40% reduction in all-
cause mortality (21). This and other studies have also shown that CRT leads to an 
improvement in symptoms and a reduction in hospitalization. The predominant mechanism 
of benefit has been considered to be improvement in both inter and intra-ventricular (LV) 
dyssynchrony. However, additional mechanisms independent of resynchronisation 
contribute to the benefit derived from CRT.  
 
Hemodynamic studies have previously demonstrated the acute (37;38;65;87;88) effects of 
CRT in patients with heart failure and a broad QRS duration. Data from studies by Kass et 
al (38) and Auricchio et al (37) demonstrated an acute 15% increase in LV dP/dtMAX   in 
response to biventricular pacing. Steendijk et al performed pressure-volume loop studies at 
6 months in patients who had undergone biventricular pacing, and demonstrated a 34% 
increase in LV stroke work and an 18% increase in LV dP/dtMAX   in response to pacing 
(89). We previously showed that LV pacing produces an acute haemodynamic benefit 
(reduced pulmonary capillary wedge pressure, increased stroke volume) in patients with 
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heart failure and a QRS<120 ms (25), although these patients had not undergone any prior 
assessment for the presence or absence of dyssynchrony. Even patients with narrow QRS 
complexes who do not have dyssynchrony might be expected to benefit from LV and 
potentially biventricular pacing by relief of diastolic ventricular interaction if present. 
 
In this study we assess the acute haemodynamic effects of both biventricular (BIVP) and 
left ventricular only pacing (LVP) in symptomatic heart failure patients with a QRS 
duration<120ms who did not meet the ‘conventional’ criteria for dyssynchrony and 
compared these effects with those demonstrated in symptomatic heart failure patients with 
a broad QRS duration who were unselected for the presence or absence of dyssynchrony. 
 
METHODS 
Patients. Thirty one patients with narrow QRS duration and 23 with broad QRS 
duration heart failure were recruited into the study. All patients had an LVEF≤35% as 
determined by echocardiography. Patients were in NYHA class III or IV despite optimal 
tolerated medical therapy that included diuretics and Angiotensin-converting enzyme 
(ACE) inhibitors. In addition, all patients with a narrow QRS ≤ 120ms had no evidence of 
inter- or intraventricular dyssynchrony. The former was defined as a Qp-Qa time delay > 
40ms, whereas the latter was defined as a septal-posterior wall motion delay > 130ms, or 
an intraventricular septal-lateral wall delay > 40ms. Patients with a narrow QRS who met 
two or more of the above criteria were excluded. Baseline patient characteristics for the 
two groups are shown in Table 3.1. 
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TABLE 3.1. Baseline patient characteristics 
 
  
  Narrow QRS (n=31) 
 
 
     Broad QRS (n=23) 
 
Age 
 
           
         62 ± 14 years 
 
          69 ± 10 years 
 
Male 
 
          
          28/31 (90%) 
         
            19/23 (83%) 
 
Ischaemic cardiomyopathy 
 
         
          17/31 (55%) 
 
            14/23 (61%) 
 
NYHA Class III 
 
          
          29/31 (94%) 
 
            21/23 (91%) 
 
NYHA Class IV 
 
           
            2/31 (6%) 
 
             2/23 (9%) 
 
LVEF 
 
         
            26 ± 5% 
 
            24 ± 7%           
 
Beta-blockers 
 
            
          25/31 (81%) 
 
          16/23 (70%)   
 
ACE-inhibitors / ARB 
 
           
          29/31(94%) 
 
          23/23 (100%) 
 
Spironolactone 
 
          
           25/31 (81%) 
 
          17/23 (74%)   
 
Diuretics 
 
          
          30/31 (97%) 
 
          23/23 (100%) 
 
Qp-Qa interval 
 
          
            15 ± 9ms 
               
                 N/A 
 
Septal-posterior wall delay 
 
          
          126 ± 54ms 
               
                 N/A 
 
Yu-dyssynchrony index 
 
           
             22 ± 7 
               
                 N/A 
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Acute Haemodynamic Studies. Acute haemodynamic studies were performed in 
the cardiac catheterization laboratory at the time of CRT device implantation with patients 
in the non-sedated and supine state. Catheterisation of the left ventricle was performed by a 
standard over-the-wire technique. The dual-field conductance catheter (CA-71103-PL 
catheter, CD Leycom, The Netherlands) was then positioned in the apex of the ventricle. 
We applied a modified parallel conductance calibration via a right atrial injection(78) to 
avoid catheterisation of the right ventricle or pulmonary artery.  
 
All data were acquired during an unforced end-expiratory breath hold. From each 
acquisition run, the derivatives of pressure and volume were calculated as the mean of the 
10 to 15 consecutive beats free from atrial or ventricular ectopic activity. Pressure-volume 
analysis was also performed during an inferior vena caval (IVC) occlusion, which reduced 
central blood volume and RV pressure acutely, achieved with a 40-mm IVC occlusion 
balloon catheter (Meditec, Boston Scientific International). Data were acquired with a 
CFL-512 system (CD Leycom), which allows further offline analysis (CircLab, Leiden 
University, The Netherlands). The haemodynamic measurements were undertaken during 
no pacing (OFF), in biventricular (BIVP) and in left ventricular only pacing (LVP) modes 
with AV intervals set at 100msec, and interventions applied in a random order, each with a 
run-in (stabilization) period of 5 minutes.  
 
The following parameters were derived from the pressure volume loops (PVL) at baseline 
(OFF), during inferior vena cava occlusion (IVCO), and in both BIVP and LVP pacing 
modes: dP/dtMAX and dP/dtMIN, absolute left ventricular stroke work (LVSW), cardiac 
output (CO) and left ventricular end-diastolic volume (LVEDV). A plot was constructed of 
beat-by-beat LV end-diastolic volume versus LVSW before and during IVC occlusion in 
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all pacing modes (the Preload Recruitable Stroke Work Relation or PRSWR).  The end-
systolic pressure volume relation (ESPVR) was determined using the single-beat method 
(EES), the end-diastolic pressure-volume relation (EDPVR) was determined using the 
single-beat method to calculate the EED and the end-diastolic stiffness constant KVED as 
described in Chapter 2.  
In order to negate the effect of any change in heart rate on systolic function (via the force-
frequency relation), a tracking VDD pacing mode was utilised to ensure a stable mean 
heart rate across all interventions (as shown in Table 3.2), with no statistically significant 
difference in heart rate between pacing modes. 
 
TABLE 3.2. Mean heart rate (beats per minute) during different pacing modes 
 
 
PACING MODE 
 
  Narrow QRS (n=31) 
 
 
     Broad QRS (n=23) 
 
OFF 
 
 
             73 bpm 
 
          70 bpm 
 
BIVP 
 
 
             76 bpm 
 
          70 bpm 
 
LVP 
 
 
             76 bpm 
 
          72 bpm 
 
Statistical Analysis. All data are expressed as the mean value ± SD. The Mann-
Whitney rank-sum test was used to compare independent samples between the two groups. 
A repeated measure ANOVA was used to assess the effect of vena caval occlusion and 
pacing if the data was normally distributed based on a Kolmogorov-Smirnov test. For data 
that was not normally distributed, a Kruskal-Wallis test was used and medians reported.  
Statistical significance was assumed at p < 0.05. 
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RESULTS 
Indices of left ventricular contractility and systolic function 
Cardiac Output 
Cardiac output was similar at baseline for the narrow and broad QRS groups (2.6 ± 0.8 vs. 
2.7 ± 0.6 l/min respectively; p=0.92). Cardiac output increased by 25% in response to both 
BIVP and LVP in the narrow QRS group (p=0.02) and by 19% in the broad QRS group 
(p=0.04). There was no significant difference between BIVP and LVP in either group, or 
between the two groups. 
 
FIGURE 3.1. The effect of biventricular (BIVP) and left ventricular pacing (LVP) on 
cardiac output (in l/min) compared with baseline values (OFF) 
 CARDIAC OUTPUT 
(litres/minute) 
 
†† † † 
PACING MODE 
Error bars indicate ± 1 SEM; †indicates a statistically significant increase from OFF 
(p<0.05) 
[42] 
 
Left ventricular stroke work (LVSW) 
LVSW was similar at baseline for the narrow and broad QRS groups (2292 ± 1060 vs. 
2110 ± 629 ml*mmHg respectively; p=0.87). LVSW increased by 26% in response to 
BIVP and 31% in response to LVP in the narrow QRS group (p=0.04) and by 32% and 
26% in the broad QRS group in response to BIVP and LVP respectively (p=0.03).  
 
FIGURE 3.2. The effect of biventricular (BIVP) and left ventricular pacing (LVP) on 
LVSW (in ml*mmHg) compared with baseline values (OFF) 
 
LVSW (ml*mmHg) 
 
†
†
†
† 
PACING MODE 
Error bars indicate ± 1 SEM; † indicates a statistically significant increase from OFF 
(p<0.05) 
 
 
 
[43] 
 
Preload recruitable stroke work (PRSW) 
PRSW was similar at baseline for the narrow and broad QRS groups (38.6 ± 20 vs. 40.2 ± 
13.4 respectively; p=0.45). PRSW increased by 34% in response to BIVP and 30% in 
response to LVP in the narrow QRS group (p=0.03) and by 37% and 29% in the broad 
QRS group in response to BIVP and LVP respectively (p=0.04). There was no significant 
difference between BIVP and LVP in either group, or between the two groups. 
 
FIGURE 3.3. The effect of BIVP and LVP on PRSW compared with baseline (OFF) 
 PRSW 
 
† 
† † † 
PACING MODE 
Error bars indicate ± 1 SEM; † indicates a statistically significant increase from OFF 
(p<0.05) 
 
 
 
 
[44] 
 
dP/dtMAX  
dP/dtMAX was significantly higher at baseline in the narrow compared with the broad QRS 
group (872 ± 189 vs. 690 ± 179 respectively; p<0.01). dP/dtMAX increased by 15% in 
response to BIVP and by 21% in response to LVP in the broad QRS group (p=0.03) and by 
13% in the narrow QRS group in response to both BIVP and LVP (p=0.04).  
 
FIGURE 3.4. Effect of BIVP and LVP on dP/dtMAX compared with baseline (OFF) 
  dP/dtMAX 
(mmHg/sec) 
  
† † 
† 
†
PACING MODE 
Error bars indicate ± 1 SEM; †indicates a statistically significant increase from OFF 
(P<0.05) 
 
 
 
 
ESPVR (EES)  
[45] 
 
There was no significant difference in the slope of the ESPVR (EES) at baseline between 
the two groups (1.1 ± 0.4 vs. 1.0 ± 0.5; p=0.45). The slope of the ESPVR (EES) increased 
by 45% in the narrow QRS group in response to both BIVP and LVP (p=0.03), and by 
30% in response to BIVP and by 50% in response to LVP in the broad QRS group 
(p=0.02).  
 
FIGURE 3.5. The effect of BIVP and LVP on EES compared with baseline (OFF) 
 EES 
(mmHg/mL/m2) 
 
† † 
† 
†
PACING MODE 
Error bars indicate ± 1 SEM; † indicates a statistically significant increase from OFF 
(p<0.05) 
 
 
 
 
Indices of left ventricular diastolic function 
[46] 
 
dP/dtMIN  
dP/dtMIN was significantly higher at baseline in the narrow compared with the broad QRS 
group (-868 ± 217 vs. -732 ± 145 respectively; p=0.04). There was no significant change in 
dP/dtMIN  in response to BIVP or LVP in either the narrow QRS (p=0.92) or the broad QRS 
group (p=0.87).   
 
FIGURE 3.6. The effect of BIVP and LVP on dP/dtMIN compared with baseline (OFF) 
 dP/dtMIN 
(mmHg/sec) 
 
PACING MODE 
 
Error bars indicate ± 1 SEM 
 
 
 
 
Tau  
[47] 
 
There was no significant difference in Tau at baseline between the two groups (83.4 ± 15 
vs. 84.6 ± 15; p=0.84). There was no significant change in Tau in response to BIVP or 
LVP in either the narrow QRS (p=0.73) or the broad QRS group (p=0.98).   
 
FIGURE 3.7. The effect of BIVP and LVP on Tau compared with baseline (OFF) 
 
Tau (msec) 
 
PACING MODE 
 
Error bars indicate ± 1 SEM 
 
 
 
 
 
 
EDPVR (EED and KVED)  
[48] 
 
There was no significant difference in either EED (p=0.60) or KVED (p=0.29) at baseline 
between the two groups. There was no significant change in either parameter in response to 
BIVP or LVP in either the narrow QRS (p=0.92) or the broad QRS group (p=0.77).   
 
FIGURE 3.8. The effect of BIVP and LVP on EED (Figure A) and KVED (Figure B) 
compared with baseline (OFF) 
  
3.8B 3.8A 
PACING MODE 
 
Error bars indicate ± 1 SEM 
[49] 
 
DISCUSSION 
 
The important findings of this study are significant acute increases in LV stroke work, 
cardiac output, and dP/dtMAX in these symptomatic patients with a narrow QRS duration and 
no conventional measures of mechanical dyssynchrony in response to both BIVP and LVP. 
Haemodynamic studies have previously demonstrated the acute effects of CRT in patients 
with heart failure and a broad QRS duration. In this study we have shown that CRT results in 
comparable acute haemodynamic improvements in patients with a narrow QRS duration to 
those with a broad QRS duration, amounting to as much as a 25% improvement in cardiac 
output and a 25 to 30% increase in absolute left ventricular stroke work.  
 
Data from studies by Kass et al (38) and Auricchio et al (37) demonstrated an acute 15% 
increase in dP/dtMAX in response to BIVP in patients with heart failure and a broad QRS 
duration, in comparison with the 13% and 15% increase we have demonstrated in the broad 
QRS and narrow QRS group of patients respectively. Steendijk et al (90) performed pressure-
volume loop studies at 6 months in patients who had undergone CRT implantation and 
demonstrated a 34% increase in LV stroke work and an 18% increase in dP/dtMAX in response 
to pacing. Prior studies have concentrated on measuring the effect of pacing on dP/dtMAX, but 
in the present study we have assessed the effect of pacing on several haemodynamic 
measures, including the effect on the slope of the preload recruitable stroke work relation, a 
far more robust measure of left ventricular contractile function as discussed in Chapter 2.  
 
Given the narrow QRS duration and the absence of conventional measures of dyssynchrony, 
these findings may at first glance be surprising. Recent evidence suggests that conventional 
measures of dyssynchrony have high inter-observer variability (32) and may underestimate 
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the magnitude of dyssynchrony because they ignore radial dyssynchrony. Current measures 
of dyssynchrony are based on echocardiographic Doppler parameters that are derived largely 
from longitudinal motion data (91). This choice of orientation is based mainly on practical 
grounds given the available echocardiographic windows for transducer positioning. However, 
because of epicardial and subendocardial fibre orientation, cardiac contraction is principally 
radial. Helm and colleagues (33) have demonstrated in a failing heart that dyssynchrony 
assessed by longitudinal motion is much less sensitive, suggesting that longitudinal motion 
data may not provide the most accurate and comprehensive means of assessing left 
ventricular dyssynchrony. Therefore, a possible explanation for the benefit observed is an 
improvement in ‘occult’ dyssynchrony. Consistent with this, there was a substantial 
improvement in the PRSWR, a load-independent and robust measure of LV contractile 
function. Whilst increases in left ventricular compliance result in a move upwards along the 
same preload recruitable stroke work relation (thereby increasing stroke work) they do not 
alter the slope of this relation, therefore an increase in the slope of this relation reflects an 
increase in left ventricular contractility. 
 
Although CRT has been shown to result in chronic symptomatic benefit and reverse 
remodelling in heart failure patients with a broad QRS duration, it is yet to be determined 
whether the acute haemodynamic benefits we have demonstrated in the patient group with a 
narrow QRS duration will translate into similar long-term benefits. Previous small studies in 
patients with a narrow QRS duration have focused on clinical and echocardiographic end-
points. Although these have shown a benefit from CRT, these studies defined a QRS duration 
of less than 150ms as ‘narrow’ and were limited to patients with evidence of dyssynchrony 
on echocardiography. In a study by Achilli et al (59) the authors report the efficacy of CRT in 
such a group of patients, with 14 of the 56 patients included having a QRS duration less than 
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120ms. These findings were supported by those of Gasparini et al (60), who reported an 
improvement in clinical and echocardiographic parameters in patients with a narrow QRS 
duration (13 of whom had a QRS of less than 120ms). The studies by Bleeker et al (61) and 
Yu et al (62) included 33 and 51 patients respectively with a QRS duration of less than 
120ms. Both studies demonstrated an improvement in clinical parameters and evidence of left 
ventricular reverse remodelling, but in addition the Yu study showed an improvement in 
exercise capacity as evidenced by an improvement in maximal metabolic equivalent achieved 
on treadmill testing(62).  
 
However, a recent and much larger study (RETHINQ) studied an implantable cardioverter 
defibrillator population who fulfilled conventional criteria for the implantation of a CRT 
device but who had a narrow QRS duration of less than 130ms (63). This study failed to 
demonstrate an improvement in exercise capacity or evidence of reverse remodelling of the 
left ventricle. The patient population in the RETHINQ study is indistinguishable from our 
patient group with regards to demographics, aetiology of heart failure, and baseline left 
ventricular function and exercise capacity. However, it is important to bear in mind that this 
patient population were an ischaemic cardiomyopathy group who primarily had an indication 
for ICD therapy, and as such were more likely to have left ventricular scar related to prior 
infarction which may have a resulted in a significant non-responder rate depending on 
positioning of the left ventricular pacing lead. It will be interesting to see whether the acute 
haemodynamic benefits we have demonstrated in the narrow QRS patient population in this 
study will translate into a long-term improvement in symptoms, quality of life, and left 
ventricular function. 
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 STUDY LIMITATIONS 
 
Patients with a narrow QRS duration were assessed for the presence or absence of inter- and 
intraventricular dyssynchrony using tissue Doppler imaging (TDI). Recent evidence suggests 
that conventional measures of dyssynchrony have high inter-observer variability and may 
also underestimate the magnitude of dyssynchrony because they ignore radial dyssynchrony. 
However, the limitation of this form of dyssynchrony analysis is that it is based on 
echocardiographic Doppler parameters which are largely derived from longitudinal motion 
data; hence the presence of radial dyssynchrony was not specifically excluded in this group of 
patients. 
 
The calibration method of the conductance catheter was not based on assessment of absolute 
volume, but this would have little effect on the results which depend entirely on relative 
changes within in each patient in response to the pacing mode.  
 
As an increase in heart rate is known to result in enhancement of systolic function via the 
force-frequency relation, an augmentation in systolic indices in the acute setting may be a 
result of an increase in heart rate alone. For this reason we used a tracking pacing mode 
(VDD) to ensure that no statistically significant differences in heart rate occurred between 
pacing modes.  
 
There was a difference in the median age of patients in the narrow versus broad QRS group, 
with the patients in the narrow QRS group being on average 7 years younger. As 
haemodynamic variables decline with age, this may account for the slightly lower indices of 
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systolic function at baseline in the broad QRS patients. However, as each patient acted as 
their own control with respect to changes in both systolic and diastolic function in response to 
the varying pacing modes, age would have no effect on the changes seen with pacing. 
 
Because of the invasive nature of the study, only a small sample of patients was studied in the 
short term, hence these results may not predict the medium and long-term effects of CRT on 
cardiac function. 
 
 
CONCLUSION 
 
In the present we demonstrate that CRT results in an improvement in acute haemodynamic 
variables in heart failure patients with a narrow QRS duration that is comparable to the 
effects seen in heart failure patients with a broad QRS duration. Detailed invasive 
haemodynamic studies (including analysis of pressure volume loop data) have previously 
been published reporting both the acute and chronic effects of CRT in patients with heart 
failure and a broad QRS duration. Although Bleasdale et al have previously demonstrated the 
beneficial effects of left ventricular pacing in narrow QRS heart failure patients with a raised 
pulmonary capillary wedge pressure, to the best of our knowledge this is the first study to 
assess the haemodynamic effects of both BIVP and LVP in a group of patients with both a 
narrow QRS duration and no evidence of significant inter- or intraventricular dyssynchrony. 
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CHAPTER 4  
 
       EFFECTS OF CARDIAC RESYNCHRONISATION  
             THERAPY ON EXTERNAL CONSTRAINT  
 
INTRODUCTION 
 
The ventricles share a common interventricular septum and, therefore, the compliance of one 
ventricle is influenced by changes in the volume, pressure or compliance of the other. This 
phenomenon has been termed diastolic ventricular interaction (DVI). The relatively non 
distensible pericardium further substantially increases ventricular interaction, since a rise in 
pressure within one ventricle will be transmitted to the other ventricle. In the resting state in 
healthy individuals, pericardial pressure is close to zero, but as the pericardium becomes 
stretched by enlargement of the ventricles it can exert a significant restraining effect on left 
ventricular filling (pericardial constraint).  
 
In heart failure patients with high pulmonary capillary wedge pressures, LV filling has been 
shown to be markedly impeded by external constraint from the right ventricle via the shared 
interventricular septum (50) and from the stretched pericardium. The application of lower 
body negative pressure (as a means of reducing venous return and preload) resulted in a 
reduction in right ventricular (RV) volume but increased left ventricular (LV) volume and 
stroke volume. This was concluded to be due to a greater reduction in external constraint 
from the RV and pericardium than the reduction in LVEDP, resulting in an increase in the 
effective filling pressure (the trans-mural gradient). Invasive haemodynamic studies by 
Dauterman et al (51) and Bleasdale et al (55) also support the presence of marked DVI in 
55 
 
patients with chronically high intra-cavitary LVEDP’s. In patients with chronic heart failure 
and a high LVEDP, balloon occlusion of the inferior vena cava removed external constraint 
to LV filling, resulting in an initial increase in LVEDV despite a fall in LVEDP (55). In a 
subsequent study by Moore et al, in a rapid pacing model of heart failure, LV volume 
increased as LVEDP was lowered, but these changes were explained entirely by a larger fall 
in external pressures, causing a rise in the trans-septal and trans-mural pressure associated 
with a rightward shift of the septum (92).  
 
The presence of DVI is likely to have important implications for the mechanism of exercise 
limitation in heart failure, since it prevents utilisation of the Starling mechanism to increase 
cardiac output (93). We hypothesized that at least part of the acute haemodynamic benefit 
from cardiac resynchronisation therapy may be due to a reduction in external constraint to LV 
filling by inducing a phase shift such that LV contraction and filling occur before they do in 
the RV. Because pericardial stretch (and therefore pericardial pressure) depends on total 
cardiac volume, a smaller RV volume during LV filling would result in less constraint to 
filling, a greater LV end-diastolic volume, and (by the Frank Starling mechanism) a greater 
LV stroke work. 
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METHODS 
Patients. Thirty one patients with narrow QRS duration and 23 with broad QRS 
duration heart failure were recruited into the study. All patients had LVEF≤35% as 
determined by echocardiography. Patients were in NYHA class III or IV despite optimal 
tolerated medical therapy that included diuretics and Angiotensin-converting enzyme (ACE) 
inhibitors. In addition, all patients with a narrow QRS ≤ 120ms had no evidence of inter- or 
intraventricular dyssynchrony. Baseline patient characteristics for the two groups are shown 
in Table 4.1. 
 
Table 4.1. Baseline patient characteristics 
 
  
  Narrow QRS (n=31) 
 
 
     Broad QRS (n=23) 
 
Age 
 
           
         62 ± 14 years 
 
          69 ± 10 years 
 
Male 
 
          
          28/31 (90%) 
         
            19/23 (83%) 
 
Ischaemic cardiomyopathy 
 
         
          17/31 (55%) 
 
            14/23 (61%) 
 
NYHA Class III 
 
          
          29/31 (94%) 
 
            21/23 (91%) 
 
NYHA Class IV 
 
           
            2/31 (6%) 
 
             2/23 (9%) 
 
LVEF 
 
         
            26 ± 5% 
 
            24 ± 7%           
 
LVEDP 
 
 
        18 ± 8mmHg 
 
         19 ± 7mmHg 
 
IVRT 
 
 
         123 ± 27ms 
 
           130 ± 27ms 
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 Acute Haemodynamic Studies. Acute haemodynamic studies were performed in the 
cardiac catheterization laboratory at the time of CRT device implantation with patients in the 
non-sedated and supine state. Catheterisation of the left ventricle was performed by a 
standard over-the-wire technique. The dual-field conductance catheter (CA-71103-PL 
catheter, CD Leycom, The Netherlands) was then positioned in the apex of the ventricle. We 
applied a modified parallel conductance calibration via a right atrial injection (78) to avoid 
catheterisation of the right ventricle.  
 
All data were acquired during an unforced end-expiratory breath hold. From each acquisition 
run, the derivatives of pressure and volume were calculated as the mean of the 10 to 15 
consecutive beats free from atrial or ventricular ectopic activity. Pressure-volume analysis 
was also performed during an inferior vena caval (IVC) occlusion, which reduced central 
blood volume and RV pressure acutely, achieved with a 40-mm IVC occlusion balloon 
catheter (Meditec, Boston Scientific International). Data were acquired with a CFL-512 
system (CD Leycom), which allows further offline analysis (CircLab, Leiden University, The 
Netherlands). The haemodynamic measurements were undertaken during no pacing (OFF), in 
biventricular (BIVP) and in left ventricular only pacing (LVP) modes with AV intervals set at 
100msec, and interventions applied in a random order, each with a run-in (stabilization) 
period of 5 minutes.  
 
The following parameters were derived from the pressure volume loops (PVL) at baseline 
(OFF), during inferior vena cava occlusion (IVCO), and in both BIVP and LVP pacing 
modes: dP/dtMAX, absolute left ventricular stroke work (LVSW), cardiac output (CO) and left 
ventricular end-diastolic volume (LVEDV). A plot was constructed of beat-by-beat LV end-
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diastolic volume versus LVSW before and during IVC occlusion in all pacing modes (the 
Preload Recruitable Stroke Work Relation or PRSWR).  External constraint (EC) to LV 
filling was determined using a modified static equilibrium technique whereby external 
constraint is quantified as the difference in LVEDP before and after removal of the 
pericardium while a constant LVEDV is maintained. The static equilibrium technique can 
only be used when the chest is open. However, a modification was applied by continuous 
measurement of LV pressure and volume during occlusion of the IVC to acutely reduce RV 
volume and pressure(51). The magnitude of external constraint was determined as described 
in Chapter 2. 
 
Statistical Analysis. All data are expressed as the mean value ± SD. The Mann-
Whitney rank-sum test was used to compare independent samples between the two groups. A 
one-way ANOVA was used to assess the effect of vena caval occlusion and pacing if the data 
was normally distributed based on a Kolmogorov-Smirnov test. For data that was not 
normally distributed, a Kruskal-Wallis test was used.  Statistical significance was assumed at 
p < 0.05. 
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 RESULTS 
 
Effects of Pacing on External Constraint (EC) 
Figure 4.1 demonstrated the response to BIVP in a patient with evidence of external 
constraint at baseline. 
 
FIGURE 4.1. The effect of BIVP on external constraint in a representative patient 
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External constraint was present in 15 of the 31 patients with a narrow QRS duration, and was 
reduced from 7.4 ± 2.8mmHg to 0.9 ± 1.2 mmHg with BIVP, and to 0.9 ± 1.4mmHg with 
LVP (p<0.01) (Figure 4.2). In those patients with a broad QRS duration, external constraint 
was present in 14 of the 23 patients, and was reduced from 8.6 ± 3.0mmHg to 2.2 ± 3.2 
mmHg with BIVP, and to 0.9 ± 1.6mmHg with LVP (p<0.01) (Figure 4.2). There was no 
significant difference between BIVP and LVP in either patient group. 
 
FIGURE 4.2. The effect of pacing on external constraint in the narrow QRS broad QRS 
patient group respectively 
 
 
 
†
EXTERNAL  
CONSTRAINT  
(mmHg) 
†
† †
PACING MODE  
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
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In those patients with evidence of external constraint and a narrow QRS duration (n=15), left 
ventricular end-diastolic volume increased from 228 ± 53ml to 248 ± 55ml in response to 
BIVP (p=NS), and to 249 ± 56ml with LVP (p=NS). In those patients with a broad QRS 
duration (n=14), left ventricular end-diastolic volume increased from 218 ± 71ml to 225 ± 
71ml in response to BIVP (p=NS), and to 224 ± 71ml with LVP (p=NS) (Figure 4.3).  
 
FIGURE 4.3. The effect of pacing on left ventricular end-diastolic volume (LVEDV) in 
the narrow QRS and broad QRS patient group respectively 
 LVEDV (ml) 
 PACING MODE 
 
 
Error bars indicate ± 1 SEM  
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Indices of systolic function in patients with and without external constraint (EC) 
Cardiac Output 
In those patients with evidence of external constraint and a narrow QRS duration (n=15), 
cardiac output increased from 2976 ± 476ml/min to 3618 ± 727ml/min in response to BIVP 
(22% increase), and to 3811 ± 717ml/min with LVP (28% increase; p=0.01). In those patients 
without evidence of external constraint and a narrow QRS duration (n=16), cardiac output 
increased from 2637 ± 628ml/min to 3253 ± 825ml/min in response to BIVP (23% increase), 
and to 3247 ± 1084ml/min with LVP (23% increase; p=0.05) (Figure 4.4A). There was no 
significant difference between BIVP and LVP in either group. 
 
FIGURE 4.4A. The effect of pacing on cardiac output (CO) in the narrow QRS patients 
with (EC) and without external constraint (NO EC) 
 
 
 
 
†
† † 
†
PACING MODE 
CARDIAC 
OUTPUT 
(litres/minute) 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
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 In those patients with a broad QRS duration and external constraint (n=14), cardiac output 
increased from 2898 ± 496ml/min to 3706 ± 710ml/min in response to BIVP (28% increase), 
and to 3760 ± 652ml/min with LVP (30% increase; p<0.01). In those patients without 
evidence of external constraint and a broad QRS duration (n=9), cardiac output increased 
from 2324 ± 330ml/min to 2686 ± 333ml/min in response to BIVP (16% increase), and to 
2535 ± 457ml/min with LVP (9% increase; p=NS) (Figure 4.4B). There was no significant 
difference between BIVP and LVP in either group. 
 
FIGURE 4.4B. The effect of pacing on cardiac output (CO) in the broad QRS patients 
with (EC) and without external constraint (NO EC) 
 
 
CARDIAC 
OUTPUT 
(litres/minute) 
 
† † 
PACING MODE  
 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
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Left Ventricular Stroke Work (LVSW) 
In those patients with evidence of external constraint and a narrow QRS duration (n=15), 
LVSW increased from 2678 ± 565ml*mmHg to 3291 ± 746ml*mmHg in response to BIVP 
(23% increase; p=NS), and to 3633 ± 1008ml*mmHg with LVP (36% increase; p=0.02). In 
those patients without evidence of external constraint and a narrow QRS duration (n=16), 
LVSW increased from 2547 ± 731ml*mmHg to 3087 ± 538ml*mmHg in response to BIVP 
(21% increase), and to 3064 ± 529ml*mmHg with LVP (20% increase; p=0.01) (Figure 
4.5A). There was no significant difference between BIVP and LVP for either group on 
pairwise comparisons. 
 
FIGURE 4.5A. The effect of pacing on left ventricular stroke work (LVSW) in the 
narrow QRS patients with (EC) and without external constraint (NO EC) 
 
  
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
†
PACING MODE  
LVSW 
(ml*mmHg) 
† 
†
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In those patients with evidence of external constraint and a broad QRS duration (n=14), 
LVSW increased from 2474 ± 557ml*mmHg to 3072 ± 464ml*mmHg in response to BIVP 
(24% increase), and to 3265 ± 458ml*mmHg with LVP (32% increase; p<0.01). In those 
patients without evidence of external constraint and a narrow QRS duration (n=9), LVSW 
increased from 2827 ± 578ml*mmHg to 3661 ± 795ml*mmHg in response to BIVP (30% 
increase; p=0.02), and to 3312 ± 506ml*mmHg with LVP (17% increase; p=NS) (Figure 
4.5B). There was no significant difference between BIVP and LVP in either group. 
 
FIGURE 4.5B. The effect of pacing on left ventricular stroke work (LVSW) in the 
broad QRS patients with (EC) and without external constraint (NO EC) 
 LVSW 
(ml*mmHg) 
 
†
† 
†
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
PACING MODE 
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Preload Recruitable Stroke Work 
In those patients with evidence of external constraint and a narrow QRS duration (n=15), 
PRSW increased from 44.2 ±11.7 to 49.3 ±11.6 in response to BIVP (12%), and to 52.9 ± 
14.6 (20%) with LVP, without reaching statistical significance. In those patients without 
evidence of external constraint and a narrow QRS duration (n=16), PRSW increased from 
44.3 ± 18.9 to 65.3 ± 20.7 in response to BIVP (47%), and to 65.6 ± 21.5 with LVP (48%; 
p<0.01) (Figure 4.6A). 
 
FIGURE 4.6A. The effect of pacing on preload recruitable stroke work (PRSW) in the 
narrow QRS patients with (EC) and without external constraint (NO EC) 
 
 
††
PRSW 
PACING MODE
 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
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In those patients with evidence of external constraint and a broad QRS duration (n=14), 
PRSW increased from 46.6 ± 10.6 to 51.0 ± 9.9 in response to BIVP (9%) and to 54.9 ± 
14.3(18%) with LVP, although neither change reach statistical significance. In those patients 
without evidence of external constraint and a narrow QRS duration (n=9), PRSW increased 
from 49.1 ± 15.8 to 76.9 ± 25.3 in response to BIVP (57%; p=0.04), and to 67.1 ± 16.5 with 
LVP (37%; p=NS) (Figure 4.6B). There was no significant difference between BIVP and 
LVP in either group. 
 
FIGURE 4.6B. The effect of pacing on preload recruitable stroke work (PRSW) in the 
broad QRS patients with (EC) and without external constraint (NO EC) 
 
 
†
PRSW 
PACING MODE 
 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
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dP/dtMAX  
In those patients with evidence of external constraint and a narrow QRS duration (n=15), 
dP/dtMAX increased from 829 ± 211 to 934 ± 193mmHg/s in response to BIVP (13%) and to 
938 ±198mmHg/s with LVP (13%), without reaching statistical significance. In those patients 
without evidence of external constraint and a narrow QRS duration (n=16), dP/dtMAX  
increased from 903 ± 171 to 1013 ± 216mmHg/s in response to BIVP (12%), and to 1011 ± 
199mmHg/s with LVP (12%), again without reaching statistical significance (Figure 4.7A). 
 
FIGURE 4.7A. The effect of pacing on dP/dtMAX in the narrow QRS patients with (EC) 
and without external constraint (NO EC)  
 
 
dP/dtMAX 
(mmHg/sec) 
Error bars indicate ± 1 SEM 
PACING MODE  
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In those patients with evidence of external constraint and a broad QRS duration (n=14), 
dP/dtMAX increased from 657 ± 197 to 759 ± 233mmHg/s in response to BIVP (16%) and to 
833 ±163mmHg/s with LVP (27%), without reaching statistical significance. In those patients 
without evidence of external constraint and a broad QRS duration (n=9), dP/dtMAX  increased 
from 732 ± 211 to 792 ± 180mmHg/s in response to BIVP (8%), and to 799 ± 189mmHg/s 
with LVP (9%), again without reaching statistical significance (Figure 4.7A). 
 
FIGURE 4.7B. The effect of pacing on dP/dtMAX in the broad QRS patients with (EC) 
and without external constraint (NO EC) 
 
 
dP/dtMAX 
(mmHg/sec) 
 PACING MODE
 
Error bars indicate ± 1 SEM 
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DISCUSSION 
 
In the present study we have demonstrated that half of the heart failure patients had evidence 
of external constraint to left ventricular filling at baseline, with a similar frequency in patients 
regardless of baseline QRS duration. This is similar to the previously reported prevalence of 
external constraint in a heart failure population using a radionuclide measurement of 
ventricular volumes during application of lower body negative pressure (50). The present 
data shows that in this heart failure population both BIVP and LVP resulted in a similar 
significant reduction in external constraint in both the broad and narrow QRS heart failure 
patients.  
 
Bleasdale et al have recently demonstrated that LV pacing ameliorated external constraint to 
LV filling by the right ventricle through the interventricular septum (diastolic ventricular 
interaction – DVI), and by the pericardium (pericardial constraint) (the combined impact of 
which is referred to as external constraint) (55). This was a more conventional patient group 
in whom the authors exclusively studied LV pacing and reported a reduction in external 
constraint. Relief of external constraint causes an acute increase in LV diastolic volume 
despite a similar LVEDP, thereby increasing stroke work by the Starling mechanism. Static 
equilibrium analysis has been used to quantify the external constraint to LV filling in animal 
models (94;95). With this technique, external constraint is quantified as the difference in 
LVEDP before and after removal of the pericardium while a constant LVEDV is maintained. 
This technique can only be used when the chest is open. However, in the present study we 
applied a modified approach by continuously measuring LV pressure and volume during 
occlusion of the IVC to acutely reduce RV volume and pressure (51). This acute reduction in 
RV volume removes external constraint to LV filling from the RV and pericardium. The 
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mechanism for the reduction in external constraint is probably related to the induction of a 
phase shift in the timing of LV filling relative to RV filling resulting in the timing of events 
being brought forward in time in the left ventricle, as previously demonstrated in a canine 
pacing model (54). Pericardial stretch, and, therefore, pericardial pressure, thus depend on 
total cardiac volume; therefore, a reduced right ventricular volume during left ventricular 
filling would be expected to result in less constraint, a greater LVEDV, and (by the Frank–
Starling mechanism) greater left ventricular stroke work.   
 
In those patients with evidence of external constraint at baseline there was trend towards a 
greater haemodynamic benefit from left ventricular pacing compared with simultaneous 
biventricular pacing, with a greater percentage increase in cardiac output, absolute left 
ventricular stroke work, preload recruitable stroke work, and dp/dtMAX in both the narrow and 
broad QRS groups. This is not unexpected, as left ventricular pacing would result in a more 
pronounced shift in the timing of events in the left ventricle relative to those occurring in the 
right ventricle than simultaneous biventricular pacing. In comparison, in those patients 
without evidence of external constraint at rest, an equivalent haemodynamic benefit was seen 
with both biventricular and left ventricular pacing, although the increase in absolute left 
ventricular stroke work and preload recruitable stroke work was greater with biventricular 
pacing. 
 
The presence of external constraint is likely to have important implications for the 
mechanisms of exercise limitation in heart failure, since it prevents utilization of the Starling 
mechanism to increase cardiac output. External constraint may help to explain why exercise 
tolerance is limited in patients with heart failure, since it prevents utilisation of the Starling 
mechanism to increase cardiac output (93).  There is indirect evidence to suggest that 
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ventricular interaction may limit the stroke volume response to exercise even in health. 
Higginbotham et al reported that in the early stages of upright exercise in man, the increase in 
cardiac output was due to an increase in both heart rate and stroke volume (mainly due to an 
increase in LVEDV with a modest increase in ejection fraction) (96). Above approximately 
50% of maximal oxygen consumption, the increase in cardiac output was due entirely to an 
increase in heart rate. There was no further increase in LVEDV, indeed in some subjects it 
fell despite an increase in PCWP. These observations may either be a consequence of DVI or 
due to the effects of a reduced diastolic filling time at higher levels of exercise but the latter 
seems unlikely because in the normal heart, the left ventricular end diastolic pressure-volume 
relation is only affected at heart rates above 170bpm (97). The failure of LVEDV to rise 
despite an increase in PCWP began at much lower heart rates. Furthermore, the observations 
of Robinson et al (98) imply that by peak exercise, the Starling mechanism cannot be utilised 
because of external constraint to filling. Consistent with this, Stray-Gundersen et al showed 
that in greyhounds pericardiectomy resulted in an increased cardiac output during the later 
stages of exercise (and also increased maximal oxygen consumption) via a greater increase in 
LVEDV (99). Venoconstriction, with an associated translocation of blood to the central 
compartment during exercise, with the resulting increase in right atrial pressure and right 
ventricular end-diastolic volume, would be expected to result in an increase in external 
constraint to left ventricular filling and a subsequent inability to augment cardiac output. 
Relief of external constraint might be expected to have a significant role in the improvement 
in exercise capacity seen in patients who respond to cardiac resynchronisation therapy. 
 
In the present study we used an invasive measure of the presence or absence of external 
constraint, namely inferior vena caval occlusion and left heart catheterisation. However, this 
method of assessment is not feasible in all heart failure patients. Similarly, assessing the 
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change in left ventricular end-diastolic volume in response to the application of lower body 
negative pressure to assess for external constraint remains a research tool and not widely 
clinically available.  
 
Echocardiography provides the simplest and easily accessible method for assessing the 
volume and pressure of the right ventricle, right atrial pressure (an excellent surrogate for 
pericardial pressure), septal position, septal motion, and the transmitral filling pattern. As 
previously described, the presence of a restrictive transmitral filling pattern has both a high 
sensitivity and specificity for detecting diastolic ventricular interaction and external 
constraint.  
 
In addition, the position of the interventricular septum at end-diastole provides valuable 
information relating to the trans-septal pressure gradient (LVEDP minus RVEDP). The 
normal interventricular septum is convex when viewed from the left ventricle, with the shape 
remaining the same in systole and diastole because the pressure in the left ventricle remains 
higher than in the right. The impact of right ventricular volume or pressure overload can lead 
to a reversal of the end-diastolic trans-septal pressure gradient, resulting in the septum 
becoming flattened or even concave at end-diastole (often in association with paradoxical 
septal motion as the septum moves rightward during systole as a result of restoration of the 
normal positive trans-septal pressure gradient). This is often seen as a delay in septal to 
posterior wall contraction on M-mode echocardiography of > 130ms. The echocardiographic 
assessment of ventricular interdependence could easily be incorporated into current protocols, 
in addition to non-invasive assessment of LVEDP using the E/E’ ratio (transmitral E wave 
velocity / tissue Doppler E velocity derived at the mitral valve annulus), in order to identify 
patients more likely to derive a significant benefit from pacing. 
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STUDY LIMITATIONS 
 
The calibration method of the conductance catheter was not based on an assessment of 
absolute volume, but this would not affect results, which depend entirely on relative changes 
within each patient in response to the pacing mode.  
 
The catheter was calibrated during steady-state at the beginning of the study. Vena caval 
occlusion, which results in a fall in RV volume, could result in a decrease in parallel 
conductance which may result in a modest underestimation of LV volume. To estimate the 
effect of IVC occlusion we assessed parallel conductance at baseline and repeated the 
measurement during a caval occlusion in 3 patients. Results show that the decrease in parallel 
conductance was less than 5% in each patient, which would translate into an apparent (i.e. 
artificial) decrease of 10ml in absolute volume at most. Because of the invasive nature of the 
study, only a small sample of patients was studied in the short-term, hence these results may 
not predict the medium and long-term effects of CRT on cardiac function. 
 
These studies were performed supine and at rest. The magnitude of ventricular interaction is 
variable; it is likely to decrease on adopting the upright posture as the RV volume decreases, 
and it is likely to increase on exercise, secondary to intestinal venoconstriction (100). Indeed, 
ventricular interaction may be an important mechanism contributing to stroke volume 
limitation and exercise intolerance in CHF (101). The present studies did not examine the 
effect of LV pacing on ventricular interaction during exercise. 
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 CONCLUSIONS 
 
This study suggests a potentially important mechanism by which cardiac resynchronisation 
therapy may produce haemodynamic benefit. Both BIVP and LVP significantly reduce 
external constraint to left ventricular filling, resulting in an increase in effective filling 
pressure; the consequent increase in LV end-diastolic volume increases stroke volume via the 
Starling mechanism. In those patients with evidence of external constraint at baseline there 
was a trend towards a greater haemodynamic benefit from left ventricular pacing compared 
with simultaneous biventricular pacing. The presence of external constraint is likely to have 
important implications for the mechanisms of exercise limitation in heart failure, since it 
prevents utilization of the Starling mechanism to increase cardiac output. 
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CHAPTER 5  
 
 
OPTIMAL INTERVENTRICULAR TIMING DELAY BASED ON      
       UNDERLYING PHYSIOLOGY AND QRS DURATION  
 
INTRODUCTION 
 
Invasive haemodynamic studies have previously demonstrated the acute beneficial effects of 
CRT in patients with heart failure and a broad QRS duration (37;38;65;87). In a recent study 
we have demonstrated comparable haemodynamic improvements in patients with heart 
failure and a narrow QRS duration (102), amounting to as much as a 25% increase in cardiac 
output and a 25-30% increase in left ventricular stroke work. Despite a marked difference in 
the QRS width induced by biventricular (BIVP) and left ventricular pacing (LVP), both 
modes of pacing have been shown to be equally efficacious at improving cardiac function in 
heart failure patients with left ventricular dyssynchrony (37;38;65;103), and indeed our study 
showed comparable benefits from BIVP and LVP in a patient group with a narrow QRS 
duration and no observable dyssynchrony (102). This similarity in acute haemodynamic 
effect suggests that mechanical rather than electrical resynchronization is responsible for the 
benefit from pacing therapy.  
 
Bordachar et al have clarified the respective mechanisms by which BIVP and LVP result in a 
haemodynamic improvement despite differing effects on the surface ECG (66). They 
demonstrated that LVP resulted in a substantial reduction in intraventricular dyssynchrony, 
but was associated with a reduction in left ventricular filling time and a longer pre-aortic 
ejection delay, thereby worsening interventricular dyssynchrony. Although intraventricular 
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delay is known to be associated with a poor prognosis in heart failure, no such data exists for 
the effects of interventricular conduction delay on prognosis (67;68).  
 
Although the predominant mechanism of improvement from CRT is thought to be a reduction 
in both inter- and intraventricular dyssynchrony, additional mechanisms independent of 
resychronisation contribute to the benefit derived. One of these mechanisms is a reduction in 
external constraint to left ventricular filling by the right ventricle and pericardium. In a 
previous study we exclusively studied LV pacing and reported a reduction in external 
constraint to left ventricular filling (55). Relief of external constraint caused an acute increase 
in LV diastolic volume despite a similar LVEDP, thereby increasing stroke work by the 
Starling mechanism. The mechanism for the reduction in external constraint is probably 
related to the induction of a phase shift in the timing of LV filling relative to RV filling (more 
pronounced with LVP compared to BIVP), resulting in the timing of events being brought 
forward in time in the left ventricle. This effectively results in LV filling occurring at a time 
when RV pressure and volume are lower; hence RV diastolic pressure and pericardial 
pressure are likely to be lower at any given LV diastolic volume. We have also shown that 
BIVP is as effective as LVP at reducing external restraint in a patient group with heart failure 
and a narrow QRS duration (102). 
 
In the present study we evaluated the acute hemodynamic effects of various interventricular 
timing delays on cardiac performance in symptomatic heart failure patients with both a 
narrow and broad QRS duration.     
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METHODS 
Patients. Twenty five heart failure patients (age 59 years ± 4; 21 to 79 years) with a 
QRS duration < 120ms and 12 heart failure patients (age 63 ± 4 years; 53 to 76 years) with a 
QRS duration > 120ms were studied. All patients had LVEF≤35% as determined by 
echocardiography. Patients were in NYHA class III or IV despite optimal tolerated medical 
therapy that included diuretics and Angiotensin-converting enzyme (ACE) inhibitors.  
Acute Haemodynamic Studies. Acute hemodynamic studies were performed in the 
cardiac catheterization laboratory at the time of CRT device implantation with patients in the 
non-sedated and supine state. Catheterization of the left ventricle was performed by a 
standard over-the-wire technique. A dual-field conductance catheter (CA-71103-PL catheter, 
CD Leycom, The Netherlands) was then positioned in the apex of the ventricle. The 
conductance catheter method provides a continuous online beat-by-beat measurement of left 
ventricular pressure and volume (74). The conductance catheter calibration has been 
described elsewhere (78). We applied a modified parallel conductance calibration via a right 
atrial injection (78) to avoid catheterization of the right ventricle or pulmonary artery.  
All data were acquired during an unforced end-expiratory breath hold. From each acquisition 
run, the derivatives of pressure and volume were calculated as the mean of the 10 to 15 
consecutive beats free from atrial or ventricular ectopic activity. Pressure-volume analysis 
was also performed during an inferior vena caval (IVC) occlusion, which reduced central 
blood volume and RV pressure acutely, achieved with a 40-mm IVC occlusion balloon 
catheter (Meditec, Boston Scientific International). Data were acquired with a CFL-512 
system (CD Leycom), which allows further offline analysis (CircLab, Leiden University, The 
Netherlands).  
The hemodynamic measurements were undertaken during no pacing (VVI), in biventricular 
pacing mode (BIVP), in left ventricular pacing (LVP) mode, and over a range of 
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interventricular timing delays. Interventions were applied in the order shown in Table 1. 
Absolute left ventricular stroke work and dP/dtMAX  were determined at each interventricular 
delay.  We quantified external constraint (EC) to LV filling using a modification of the static 
equilibrium technique as previously described by us (55). 
 
Table 5.1. Interventricular timing delays 
V-V INTERVAL A-V INTERVAL  
Pacing OFF   
RV-LV 80ms 20ms  
 
RV-LV 40ms 60ms  RV LEAD 
RV-LV 20ms 80ms  
RV-LV 12ms 90ms  
BIVP 100ms SIMULTANEOUS 
LV-RV 12ms 100ms  
LV-RV 20ms 100ms  
LV-RV 40ms 100ms LV LEAD 
LV-RV 80ms 100ms  
LVP 100ms  
 
Statistical Analysis. All data are expressed as the mean value ± SD. A one-way 
ANOVA was used if the data was normally distributed based on a Kolmogorov-Smirnov test. 
For data that was not normally distributed, a Kruskal-Wallis test was used.  Statistical 
significance was assumed at p<0.05.   
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RESULTS 
Effect of interventricular timing delay on dP/dtMAX   
dP/dtMAX  decreased in response to pacing with a V-V delay of RV first by 80ms, but 
increased in response to all other programmed interventricular delays. However, only V-V 
delays in which the LV led by > 20ms resulted in a significant increase in dP/dtMAX  from 
baseline values (p<0.05) (Figure 5.1A.). Percentage changes from baseline and from 
simultaneous BIVP for all programmed V-V delays are shown in Figure 5.1B and 5.1C 
respectively. 
 
Figure 5.1A.  dP/dtMAX  at different V-V delays 
 dP/dtMAX   
(mmHg/sec) 
 
†† † †
Programmed interventricular timing delay (in milliseconds) 
 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
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Figure 5.1B.  Percentage change in dP/dtMAX from OFF   
 % change 
in dP/dtMAX   
 
Programmed interventricular timing delay  
 
Figure 5.1C.  Percentage change in dP/dtMAX using BIVP as a comparator 
  % change 
in dP/dtMAX   
 Programmed interventricular timing delay  
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Effect of interventricular timing delay on LVSW 
LVSW decreased in response to pacing with a V-V delay of RV first by 80ms, but increased 
in response to all other programmed interventricular delays. All V-V delays ranging from RV 
first by 12ms through to LVP only resulted in a significant increase in LVSW from baseline 
values (p<0.05) (Figure 5.2A.). Percentage changes from baseline and simultaneous BIVP for 
all programmed V-V delays are shown in Figure 5.2B and 5.2C respectively. 
 
Figure 5.2A.  LVSW at different V-V delays 
 
 
LVSW  
(ml*mmHg)  
 
† † † ††† †
Programmed interventricular timing delay (in milliseconds) 
 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
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Figure 5.2B.  Percentage change in LVSW from OFF 
 % change 
in LVSW 
 
Programmed interventricular timing delay  
 
Figure 5.2C.  Percentage change in LVSW using BIVP as a comparator 
 % change 
in LVSW 
 
Programmed interventricular timing delay   
84 
 
Optimal interventricular timing delay in patients with and without external constraint 
Effect on dP/dtMAX   
dP/dtMAX  decreased in response to pacing with a V-V delay of RV first by 80ms, but 
increased in response to all other programmed interventricular delays in both groups. There 
was a trend towards a greater increase in dP/dtMAX  with those parameters were the LV was 
the first chamber paced, although it did not reach statistical significance (Figure 5.3A). 
Percentage changes from OFF and simultaneous BIVP for all programmed V-V delays are 
shown in Figure 5.3B and 5.3C respectively. 
 
Figure 5.3A.  dP/dtMAX  at various V-V delays in those patients with (EC) and without 
external constraint (NO EC) 
 dP/dtMAX  
(mmHg/sec) 
 
Programmed interventricular timing delay 
 
Error bars indicate ± 1 SEM 
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Figure 5.3B.  Percentage change in dP/dtMAX  from OFF in patients with (EC) and 
without external constraint (NO EC) 
 
% change 
in dP/dtMAX   
Programmed interventricular timing delay 
 
Figure 5.3C.  Percentage change in dP/dtMAX  using BIVP as a comparator in patients 
with (EC) and without external constraint (NO 
EC)% change 
in dP/dtMAX   
Programmed interventricular timing delay 
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 Effect on LVSW   
LVSW decreased in response to pacing with a V-V delay of RV first by 80ms, but increased 
in response to all other programmed interventricular delays in both groups. The data for 
grouped V-V timing delays is shown below. In the patients with external constraint, there was 
a trend towards a greater increase in LVSW with those interventricular delays where the LV 
was the first chamber paced (Figure 5.4A). In those patients without external constraint, 
interventricular delays ranging from the RV leading by 12ms to the LV leading my 20ms 
appeared to be optimal. Percentage changes from baseline and simultaneous BIVP for all 
programmed V-V delays are shown in Figure 5.4B and 5.4C respectively. 
 
Figure 5.4A.  LVSW at various grouped V-V delays in those patients with (EC) and 
without external constraint (NO EC) 
 LVSW 
(ml*mmHg) 
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 † 
† 
†
† †
Programmed interventricular timing delay 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
Figure 5.4B.  Percentage change in LVSW from OFF in patients with (EC) and without 
external constraint (NO EC) 
 
% change in 
LVSW 
Programmed interventricular timing delay 
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Figure 5.4C.  Percentage change in LVSW using BIVP as a comparator in patients with 
(EC) and without external constraint (NO EC) 
 
% change in 
LVSW 
Optimal interventricular timing delay – narrow versus broad QRS duration  
Programmed interventricular timing delay 
Effect on dP/dtMAX   
dP/dtMAX  decreased in response to pacing with a V-V delay of RV first by 80ms, but 
increased in response to all other programmed interventricular delays in both groups. The 
data for grouped V-V delays is shown below. There was a trend towards a greater increase in 
dP/dtMAX  with those parameters were the LV was the first chamber paced, although this did 
not reach statistical significance (Figure 5.5A). Percentage changes from baseline and 
simultaneous BIVP for all programmed V-V delays are shown in Figure 5.5B and 5.5C 
respectively. 
 
Figure 5.5A.  dP/dtMAX  at various V-V delays according to baseline QRS duration 
 dP/dtMAX  
(mmHg/sec) 
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 Error bars indicate ± 1 SEM 
Programmed interventricular timing delay 
 
Figure 5.5B.  Percentage change in dP/dtMAX from OFF according to baseline QRS  
 % change in 
dP/dtMAX 
 
Programmed interventricular timing delay
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 Figure 5.5C.  Percentage change in dP/dtMAX  using BIVP as a comparator according to 
baseline QRS 
 
% change in 
dP/dtMAX 
Programmed interventricular timing delay 
Effect on LVSW   
LVSW decreased in response to pacing with a V-V delay of RV first by 80ms, but increased 
in response to all other programmed interventricular delays in both groups. The data for 
grouped V-V delays are shown below. There was a significantly greater increase in LVSW 
with those parameters where the LV was the first chamber paced (p<0.01) (Figure 5.6A). 
Percentage changes from baseline and simultaneous BIVP for all programmed V-V delays 
are shown in Figure 5.6B and 5.6C respectively. 
 
Figure 5.6A.  LVSW at various V-V delays according to baseline QRS duration 
 LVSW 
(ml*mmHg) 
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 † 
†
† 
† 
Programmed interventricular timing delay
 
Error bars indicate ± 1 SEM; † indicates a significant change from OFF (p<0.05) 
Figure 5.6B.  Percentage change in LVSW  from OFF according to baseline QRS  
 % change in 
LVSW 
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Programmed interventricular timing delay
 
Figure 5.5C.  Percentage change in dP/dtMAX  using BIVP as a comparator according to 
baseline QRS  
 
% change 
in LVSW 
Programmed interventricular timing delay
DISCUSSION 
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In the present study we have demonstrated a significant increase in dP/dtMAX  in response to 
V-V delays in which the LV led by >20ms, and a significant increase in LVSW in response 
to V-V delays ranging from RV first by 12ms through to LVP. In addition, we have 
demonstrated the acute detrimental haemodynamic effect of right ventricular pacing in 
patients with heart failure and severe left ventricular impairment.  
 
In patients with significant external constraint to left ventricular filling, there was a trend 
towards a greater increase in LVSW with those interventricular delays where the LV was the 
first chamber paced, whereas is patients without external constraint, in whom interventricular 
delays ranging from the RV leading by 12ms to the LV leading my 20ms appeared to be 
optimal. 
 
Although numerous pivotal randomized controlled trials have demonstrated the efficacy of 
CRT in patients with medically refractory symptomatic heart failure, several issues remain 
regarding the indications for implant, optimal programming parameters, and the role of 
atrioventricular (A-V) and interventricular (V-V) optimization. Acute haemodynamic studies 
comparing sequential with simultaneous ventricular stimulation have demonstrated a 
significant increase in LV dP/dtMAX  when the LV was stimulated before the RV (104;105). 
An observational echocardiographic study utilizing tissue tracking to optimize 
interventricular timings has demonstrated a significant long-term improvement in left 
ventricular function when sequential rather than simultaneous stimulation was applied (106). 
In a study by Vidal et al, utilizing both echocardiographic and electrocardiographic 
parameters to optimize CRT programming in a patient group with LBBB, the authors 
demonstrated that LV leading RV activation by 30ms was the optimal V-V delay in the 
majority of patients (107). In addition, sequential biventricular stimulation has been shown to 
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decrease the severity of mitral regurgitation and improve LV synchronicity compared with 
the simultaneous pacing of both ventricles (66; 104).  
 
In our study, patients with significant external constraint to left ventricular filling at baseline 
showed a greater increase in LVSW when the LV was the first chamber paced, with an 
incremental increase the greater the programmed delay between LV and RV. This was in 
contrast to patients without external constraint, in whom more simultaneous interventricular 
delays ranging from the RV leading by 12ms to the LV leading my 20ms appeared to be 
optimal. This can be explained by the effect of LV pacing on the timing of events in the left 
and right ventricle respectively. We recently demonstrated that LV pacing ameliorated 
external constraint to LV filling by the right ventricle through the interventricular septum 
(diastolic ventricular interaction – DVI), and by the pericardium (pericardial constraint)  (the 
combined impact of which we refer to as external constraint) (55). In addition, in a recent 
study we have shown that both BIVP and LV pacing significantly reduce external constraint 
in a heart failure population with a narrow QRS duration and no significant dyssynchrony on 
echocardiography (102). In a previous study in a more conventional patient group we 
exclusively studied LV pacing and reported a reduction in external constraint (55).  
 
Relief of external constraint causes an acute increase in LV diastolic volume despite a similar 
LVEDP, thereby increasing stroke work by the Starling mechanism. With this technique, 
external constraint is quantified as the difference in LVEDP before and after removal of the 
pericardium while a constant LVEDV is maintained. This technique can only be used when 
the chest is open. However, in the present study we applied a modified approach by 
continuously measuring LV pressure and volume during occlusion of the IVC to acutely 
reduce RV volume and pressure (51). This acute reduction in RV volume removes external 
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constraint to LV filling from the RV and pericardium. The mechanism for the reduction in 
external constraint is probably related to the induction of a phase shift in the timing of LV 
filling relative to RV filling (more pronounced with LVP compared to BIVP), resulting in the 
timing of events being brought forward in time in the left ventricle. This effectively results in 
LV filling occurring at a time when RV pressure and volume are lower; hence RV diastolic 
pressure and pericardial pressure are likely to be lower at any given LV diastolic volume. It 
would appear from our current data that an incremental benefit can be achieved by increasing 
the degree of LV pre-activation beyond 20ms. 
 
Whether these acute haemodynamic effects associated with interventricular optimization will 
translate into chronic symptomatic benefit remains to be determined. The RHYTHM II ICD 
trial, which utilized echocardiography to optimize the V-V interval in patients receiving a 
CRT-D device, demonstrated no additional benefit of interventricular timing optimization at 
6 months compared with empiric programming parameters (108). Similarly, the 
DECREASE-HF trial showed comparable improvements in LV volumes and 
echocardiographic parameters with simultaneous biventricular and sequential pacing, with a 
trend towards a greater reduction in LV volumes with simultaneous pacing (109). However, 
the programmed V-V interval in this study was based on intrinsic conduction only. In 
contrast, the recent INSYNC III study demonstrated an increase in left ventricular stroke 
volume with sequential biventricular stimulation (with the optimal V-V interval determined 
by echocardiography in individual patients) (110).  
 
Despite conflicting results, V-V optimization may prove beneficial in some patients who 
demonstrate no or a suboptimal response to CRT, and may partially compensate for 
suboptimal LV lead positions in difficult cases. It may also allow for correction of individual 
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heterogeneous ventricular activation patterns (including areas of slow conduction related to 
scar near the LV pacing site) (111). Although many would argue that the optimal V-V delay 
shows great variability and must be individualized, we have demonstrated optimal V-V 
delays in patient groups based on the presence or absence of external constraint.  
 
 
STUDY LIMITATIONS 
 
The calibration method of the conductance catheter was not based on assessment of absolute 
volume, but this would not affect results, which depend entirely on relative changes within 
each patient in response to the pacing mode.  
 
Because of the invasive nature of the study, only a small sample of patients was studied in the 
short-term, hence these results may not predict the medium and long-term effects of CRT on 
cardiac function. 
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CONCLUSION 
 
In the present study we have demonstrated a significant increase in both dP/dtMAX  and LVSW 
in response to V-V delays in which the LV led by >20ms, In patients with external constraint, 
there was a trend towards a greater increase in LVSW with those interventricular delays 
where the LV was the first chamber paced, compared with patients without external 
constraint, in whom near-simultaneous interventricular delays ranging from the RV leading 
by 12ms to the LV leading by 20ms appeared to be optimal. Although many would argue that 
the optimal V-V delay shows great variability and must be individualized, we have 
demonstrated optimal V-V delays in patient groups based on the presence or absence of 
external constraint.  
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CHAPTER 6  
 
       MECHANISMS BY WHICH CARDIAC RESYNCHRONISATION     
                 THERAPY IMPROVES CARDIAC PERFORMANCE  
                                         IN HEART FAILURE              
 
 
INTRODUCTION 
Recent trials in selected patients with heart failure have shown that biventricular pacing in which the 
two ventricles are paced synchronously (or one ventricle slightly before the other), improves 
symptoms, and reduces number of hospitalisations and hospital bed days (18;20). Currently the 
therapy is reserved for patients with NYHA III and IV Class symptoms despite optimal medical 
therapy who have prolonged QRS durations (>120msec).  The latter is based on the original 
rationale that biventricular pacing acts via an improvement in cardiac ‘electrical synchrony’, hence 
the frequently used term “resynchronization therapy”.  It is becoming increasingly evident that 
mechanical resynchronisation is an important contributor to the benefit but that this is dissociated to 
a considerable extent from electrical resynchronisation  Inco-ordinate ventricular contraction is 
frequently present in CHF and contributes to impaired overall contractile function (38).  We and 
others have shown that biventricular pacing, particularly with the LV pacing electrode pacing the LV 
free wall, reduces LV mechanical dyssynchrony (25;65;112). Mechanical dyssynchrony is not 
however limited to broad QRS patients (28) and we  recently showed that biventricular pacing also 
reduced mechanical dyssynchrony in narrow QRS patients (25). 
In addition, short AV delay pacing reduces pre-systolic mitral regurgitation (113). The presence and 
magnitude of the latter is related to left ventricular end diastolic pressure (LVEDP) and to 
prolongation of the A-V interval. Pacing leads to an increase in the effective diastolic filling period 
by a reduction in pre-systolic mitral regurgitation.  However this is believed to make only a modest 
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contribution to the overall haemodynamic benefit of biventricular pacing in the majority of patients. 
Biventricular pacing may also reduce the magnitude of systolic ‘functional’ mitral regurgitation,  by 
a reduction in ventricular sphericity, and/or by an increase in mitral valve ‘closing pressure’ leading 
to improved coaptation of the mitral valve leaflets (39;114). 
Whilst the large chronic studies published to date have assessed biventricular pacing, left ventricular 
pacing has produced equivalent or superior acute haemodynamic and chronic symptomatic benefits 
compared with biventricular pacing (65;112).  We and others have shown that although LV pacing 
typically prolongs QRS duration and increases ‘electrical dyssynchrony’, it nevertheless reduces 
mechanical dyssynchrony in both broad and narrow QRS heart failure (25;38). Recently we have 
demonstrated an additional potential mechanism by which both LV pacing (55) and biventricular 
pacing (55;102) improve haemodynamics in patients with heart failure via a reduction in external 
constraint to left ventricular filling. 
Currently approximately 30% of patients with broad complex QRS complexes who undergo 
biventricular pacing derive no benefit.  Conversely some patients with narrow QRS complexes (who 
do not fulfill current criteria) may benefit.  A better understanding of the mechanisms of benefit of 
biventricular and left ventricular pacing may lead to improved patient selection and optimisation of 
pacing strategy in individual patients.  
This study will assess the mechanisms by which biventricular and left ventricular pacing improves    
acute haemodynamic performance in patients with heart failure. It will assess the relative 
contributions of reduced diastolic ventricular interaction, reduced mitral regurgitation and enhanced 
contractility to the acute benefit of each pacing modality in CHF patients with both narrow and wide 
QRS complexes. The findings will inform better patient selection for this therapy and also 
optimisation of pacing strategy (biventricular vs. left ventricular) in individual patients. 
 
 
100 
 
METHODS 
Patients. Thirty one patients with narrow QRS duration and 23 with broad QRS 
duration heart failure were recruited into the study. All patients had an LVEF≤35% and had 
NYHA class III or IV symptoms despite optimal tolerated medical therapy. In addition, all 
patients with a narrow QRS ≤ 120ms had no evidence of inter- or intraventricular 
dyssynchrony. Baseline patient characteristics for the two groups are shown in Table 6.1. 
 
 
TABLE 6.1. Baseline patient characteristics 
 
  
  Narrow QRS (n=31) 
 
 
     Broad QRS (n=23) 
 
Age 
 
           
         62 ± 14 years 
 
          69 ± 10 years 
 
Male 
 
          
          28/31 (90%) 
         
            19/23 (83%) 
 
Ischaemic cardiomyopathy 
 
         
          17/31 (55%) 
 
            14/23 (61%) 
 
NYHA Class III 
 
          
          29/31 (94%) 
 
            21/23 (91%) 
 
NYHA Class IV 
 
           
            2/31 (6%) 
 
             2/23 (9%) 
 
LVEF 
 
         
            26 ± 5% 
 
            24 ± 7%           
 
Qp-Qa interval 
 
          
            15 ± 9ms 
               
                 N/A 
 
Septal-posterior wall delay 
 
          
          126 ± 54ms 
               
                 N/A 
 
Yu-dyssynchrony index 
 
           
             22 ± 7 
               
                 N/A 
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Acute Haemodynamic Studies. Acute haemodynamic studies were performed in the 
cardiac catheterization laboratory at the time of CRT device implantation with patients in the 
non-sedated and supine state. Catheterisation of the left ventricle was performed by a 
standard over-the-wire technique. The dual-field conductance catheter (CA-71103-PL 
catheter, CD Leycom, The Netherlands) was then positioned in the apex of the ventricle. We 
applied a modified parallel conductance calibration via a right atrial injection (78) to avoid 
catheterisation of the right ventricle or pulmonary artery.  
All data were acquired during an unforced end-expiratory breath hold. From each acquisition 
run, the derivatives of pressure and volume were calculated as the mean of the 10 to 15 
consecutive beats free from atrial or ventricular ectopic activity. Pressure-volume analysis 
was also performed during an inferior vena caval (IVC) occlusion, which reduced central 
blood volume and RV pressure acutely, achieved with a 40-mm IVC occlusion balloon 
catheter (Meditec, Boston Scientific International). Data were acquired with a CFL-512 
system (CD Leycom), which allows further offline analysis (CircLab, Leiden University, The 
Netherlands). The haemodynamic measurements were undertaken during no pacing (OFF), in 
biventricular (BIVP) and in left ventricular only pacing (LVP) modes with AV intervals set at 
100msec, an interventions applied in a random order, each with a run-in (stabilization) period 
of 5 minutes.  
 
The following parameters were derived from the pressure volume loops (PVL) at baseline 
(OFF), during inferior vena cava occlusion (IVCO), and in both BIVP and LVP pacing 
modes: dP/dtMAX and dP/dtMIN, absolute left ventricular stroke work (LVSW), cardiac output 
(CO) and left ventricular end-diastolic volume (LVEDV). A plot was constructed of beat-by-
beat LV end-diastolic volume versus LVSW before and during IVC occlusion in all pacing 
modes (the Preload Recruitable Stroke Work Relation or PRSWR).   
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Assessment of the magnitude of acute haemodynamic benefit of LVP and BIVP which is 
due to a reduction of DVI versus improved LV contractile function 
 External constraint was quantified as described in Chapter 2. A plot was constructed of beat 
by beat left ventricular end-diastolic volume (LVEDV) versus left ventricular stroke work (LVSW) 
before and during inferior vena caval occlusion with pacing OFF, BIVP and LVP.  The slope of this 
relation, the Preload Recruitable Stroke Work relation (PRSW) and is a load-independent measure of 
LV contractile function.  
Fig 6.1 is such a plot from a patient in whom LVP increased LVSW almost exclusively via 
relief of external constraint, resulting in preload recruitment. The pacing OFF inferior vena caval 
occlusion (IVCO) run is shown in grey squares with the pre-IVCO occlusion point shown as the 
large grey square. The corresponding LVP parameters are shown in black squares. Note the slope of 
the LVEDV/LVSW (preload recruitable stroke work-PRSW) is unchanged by pacing. This implies 
that the increase in absolute LVSW is entirely due to a higher end-diastolic volume (due to relief of 
external constraint). 
FIGURE 6.1. Improvement in LVSW due to preload recruitment/relief of external constraint 
 
LVSW 
LVEDV 
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 Fig 6.2 is a plot from a patient in whom LVP increased LVSW almost exclusively via enhanced 
contractility. The pacing OFF inferior vena caval occlusion (IVCO) run is shown in grey squares 
with the pre-IVCO occlusion point shown as the large grey square. The corresponding LVP 
parameters are shown in black squares. Note the slope of the LVEDV/LVSW (preload recruitable 
stroke work-PRSW) is steeper with LVP, without an acute change in LVEDV. This implies that the 
increase in absolute LVSW is entirely due to enhanced contractility.  
 
FIGURE 6.2. Improvement in LVSW due to enhanced contractility 
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Using such plots we assessed the contribution of preload recruitment (i.e. relief of external 
constraint) versus enhanced contractility to the increase in LV stroke work for both LVP and BIVP. 
The contribution of each was then calculated as shown in figure 6.3.  
 
FIGURE 6.3. Improvement in LVSW due to enhanced contractility 
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Assessment of the pre-systolic mitral regurgitation  
Pre-systolic mitral regurgitation was assessed from the pressure-volume loop as the 
difference between the maximum left ventricular volume and the volume at end-diastole just 
prior to the onset of isovolaemic contraction, as shown in Figure 6.4. 
 
Figure 6.4. Assessment of pre-systolic mitral regurgitation (PSMR) 
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Statistical Analysis. All data are expressed as the mean value ± SD. The Mann-
Whitney rank-sum test was used to compare independent samples between the two groups. A 
one-way ANOVA was used to assess the effect of vena caval occlusion and pacing if the data 
was normally distributed based on a Kolmogorov-Smirnov test. For data that was not 
normally distributed, a Kruskal-Wallis test was used.  Statistical significance was assumed at 
p < 0.05. 
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RESULTS 
Contribution to increased LVSW 
Heart Failure Group (Narrow and Broad QRS Groups)  
For the heart failure group as a whole, both BIVP and LVP resulted in a greater increase in 
LVSW in those patients with external constraint (n=29) compared with those without (n=25). 
LVP resulted in a significantly greater increase in LVSW inthose with external constraint 
than those without. Results are shown in Figure 6.5.  
 
Figure 6.5. Absolute increase in LVSW in patients with (EC) and without (NO EC) 
external constraint for the heart failure group as a whole 
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Error bars indicate ± 1 SEM 
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For the heart failure group with external constraint as a whole (n=29), preload recruitment 
resulted in a significantly greater contribution to the increase in absolute LVSW compared 
with enhanced LV contractility (65% versus 35% respectively; p < 0.01). The percentage 
contributions were identical for both BIVP and LVP, although LVP resulted in a greater 
absolute gain in LVSW compared with BIVP (911 versus 743ml*mmHg respectively) 
without reaching statistical significance. Results are shown in Figure 6.6 and 6.7. 
 
 
Figure 6.6. Relative percentage contributions of preload recruitment and enhanced 
contractility for the heart failure group as a whole 
 % contribution to 
absolute LVSW gain 
 PACING MODE 
 
Error bars indicate ± 1 SEM 
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Figure 6.7. Absolute increase in LVSW due to preload recruitment and enhanced 
contractility for the heart failure group as a whole 
 
 
Increase in LVSW 
(ml*mmHg) 
Error bars indicate ± 1 SEM 
 
Narrow QRS Group  
For the narrow QRS group with external constraint (n=16), preload recruitment resulted in a 
significantly greater contribution to the increase in absolute LVSW compared with enhanced 
LV contractility (70% versus 30% respectively; p < 0.01). The percentage contributions were 
again identical for both BIVP and LVP, although LVP resulted in a greater absolute in 
LVSW compared with BIVP (995 versus 736ml*mmHg respectively) without reaching 
statistical significance. Results are shown in Figure 6.8 and 6.9. 
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Figure 6.8. Relative percentage contributions of preload recruitment and enhanced 
contractility for the narrow QRS group with external constraint 
 
 
Error bars indicate ± 1 SEM 
 
Figure 6.9. Absolute increase in LVSW due to preload recruitment and enhanced 
contractility for the narrow QRS group with external constraint 
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Broad QRS Group  
For the broad QRS group with external constraint (n=14), preload recruitment resulted in a 
similar contribution to the increase in absolute LVSW as enhanced LV contractility (54% 
versus 46% respectively for BIVP and 58% versus 42% for LVP; p = NS). The absolute gain 
in LVSW was similar for both LVP and BIVP (806 versus 837ml*mmHg respectively). 
Results are shown in Figure 6.10 and 6.11. 
 
Figure 6.10. Relative percentage contributions of preload recruitment and enhanced 
contractility for the broad QRS group with external constraint 
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Figure 6.11. Absolute increase in LVSW due to preload recruitment and enhanced 
contractility for the broad QRS group with external constraint 
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Components of preload recruitment  
Heart Failure Group  
For the heart failure group with external constraint as a whole (n=29), relief of external 
constraint resulted in a significantly greater contribution to the increase in LVEDV compared 
with a reduction in pre-systolic mitral regurgitation (84% versus 16% with BIVP and 83% 
versus 17% with LVP; p < 0.01). Results are shown in Figure 6.12. 
 
 
Figure 6.12. Relative percentage contributions of relief of external constraint (EC) and 
reduction in pre-systolic mitral regurgitation (PSMR) for the heart failure group as a 
whole with external constraint 
 % contribution to 
preload recruitment 
 
Error bars indicate ± 1 SEM 
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Narrow QRS Group  
For the narrow QRS group with external constraint (n=16), relief of external constraint 
resulted in a significantly greater contribution to the increase in LVEDV compared with a 
reduction in pre-systolic mitral regurgitation (84% versus 16% with BIVP and 75% versus 
25% with LVP; p < 0.01). Results are shown in Figure 6.13. 
 
 
Figure 6.13. Relative percentage contributions of relief of external constraint and 
reduction in pre-systolic mitral regurgitation for the narrow QRS group 
 % contribution to 
preload recruitment 
Error bars indicate ± 1 SEM 
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Broad  QRS Group  
For the broad QRS group with external constraint (n=14), relief of external constraint 
resulted in a significantly greater contribution to the increase in LVEDV compared with a 
reduction in pre-systolic mitral regurgitation (84% versus 16% with BIVP and 94% versus 
6% with LVP; p < 0.01). Results are shown in Figure 6.14. 
 
Figure 6.14. Relative percentage contributions of relief of external constraint and 
reduction in pre-systolic mitral regurgitation for the broad QRS group 
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Error bars indicate ± 1 SEM 
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DISCUSSION 
 
In the present study we have demonstrated that in a group of heart failure patients with 
evidence of external constraint at rest, the acute haemodynamic benefits of both BIVP and 
LVP are principally due to preload recruitment (accounting for two-thirds of the absolute 
gain in left ventricular stroke work). For the group as a whole, there was a greater absolute 
increase in LVSW in those patients with external constraint compared to those without. This 
suggests that patients with external constraint may derive a greater haemodynamic benefit 
from pacing due to the significant increase in stroke work that is associated with relief of 
external constraint and preload recruitment, in addition to the increase in stroke work derived 
from enhanced contractility due to a reduction in dyssynchrony.  
 
As expected, in the patients with a narrow QRS duration and no evidence of significant inter- 
or intra-ventricular dyssynchrony on baseline echocardiography, the predominant mechanism 
responsible for the increase in LVSW in response to LVP was preload recruitment 
(accounting for 70% of the absolute increase). LVP has previously been shown to be 
effective in reducing external constraint to left ventricular filling in heart failure patients 
undergoing CRT (55;102), and in those patients with a narrow QRS duration (102). The 
mechanism for the reduction in external constraint is related to the induction of a phase shift 
in the timing of LV filling relative to RV filling resulting in the timing of events being 
brought forward in time in the left ventricle, as previously demonstrated in a canine pacing 
model (54). Surprisingly, the contribution of preload recruitment to the overall gain in LVSW 
was similar in response to BIVP, despite the absence of electrical or mechanical 
dyssynchrony in this group of patients. This may be related to the presence of occult 
mechanical dyssynchrony in this group of patients, but could still be explained by the 
induction of a less pronounced phase-shift in the timing of left and right ventricular events. 
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Although the relative contributions of preload recruitment and enhanced contractility were 
similar for both pacing modes, the overall increase in total LVSW in the narrow QRS group 
was greater with LVP than BIVP. This was as a result of a combination of LVSW gain due to 
both preload recruitment and enhanced contractility. 
 
In those patients with a broad QRS duration, as manifest by a left bundle branch block on 
surface electrocardiography, the contribution of preload recruitment and enhanced 
contractility were relatively similar, with no significant difference between BIVP and LVP. 
This group of patients had a traditional indication for cardiac resynchronisation therapy based 
on current clinical guidelines, and all had evidence of electrical dyssynchrony at baseline 
(QRS duration > 120ms). This group of patients would be expected to derive a benefit not 
only from the relief of external constraint, but also a significant increase in left ventricular 
contractility via a reduction in left ventricular dyssynchrony. In keeping with our current 
data, the contribution of enhanced contractility would be expected to be greater in a patients 
group with a broad QRS duration compared with those with a narrow QRS. The overall 
increase in total LVSW was similar in response to both BIVP and LVP, suggesting that in 
patients in whom relief of dyssynchrony is as important as relief of external constraint, there 
may be no significant additional benefit from LVP, compared with a narrow QRS patient 
group in whom resynchronisation plays less of a role and relief of external constraint a 
greater one.   
The increase in left ventricular end-diastolic volume with pacing resulted due to both a relief 
of external constraint and a reduction in pre-systolic mitral regurgitation. Relief of external 
constraint played a significantly greater role in preload recruitment, accounting for over 80% 
of the volume gain. The subsequent increase in LVEDV results in a greater LVSW due to 
recruitment of contractility via the Frank-Starling mechanism. 
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 Prolongation of the atrio-ventricular (AV) conduction time leading to AV dyssynchrony is 
common in patients with heart failure (22).  Prolongation of the AV interval generates pre-
systolic mitral regurgitation by generating a diastolic ventricular-atrial pressure gradient. This 
is because the end of atrial contraction occurs much earlier than the onset of the rise in 
intraventricular pressure. Because of the altered geometry within a dilated left ventricle, 
appropriate mitral or tricuspid closure is probably not complete until the start of ventricular 
contraction. This results in a lower left ventricular preload, higher pulmonary capillary wedge 
pressure, and a decreased cardiac output. The reduction in pre-systolic mitral regurgitation in 
these patients occurred as a result of short A-V delay pacing at an interval of 100ms, in 
keeping with previous data from Brecker et al (4) showing that pacing with short AV 
intervals can reduce or abolish diastolic mitral regurgitation. 
 
STUDY LIMITATIONS 
 
Patients with a narrow QRS duration were assessed for the presence or absence of inter- and 
intraventricular dyssynchrony using tissue Doppler imaging (TDI). Recent evidence suggests 
that conventional measures of dyssynchrony have high inter-observer variability and may 
also underestimate the magnitude of dyssynchrony because they ignore radial dyssynchrony. 
However, the limitation of this form of dyssynchrony analysis is that it is based on 
echocardiographic Doppler parameters which are largely derived from longitudinal motion 
data; hence the presence of radial dyssynchrony was not specifically excluded in this group of 
patients. 
 In addition, patients with a broad QRS duration were not formally assessed for the presence 
or absence of mechanical dyssynchrony on echocardiography. 
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The calibration method of the conductance catheter was not based on assessment of absolute 
volume, but this would have little effect on the results which depend entirely on relative 
changes within in each patient in response to the pacing mode. The catheter was calibrated 
during steady-state at the beginning of the study. Vena caval occlusion, which results in a fall 
in RV volume, could result in a decrease in parallel conductance which may result in a 
modest underestimation of LV volume. To estimate the effect of IVC occlusion we assessed 
parallel conductance at baseline and repeated the measurement during a caval occlusion in 3 
patients. Results show that the decrease in parallel conductance was less than 5% in each 
patient, which would translate into an apparent (i.e. artificial) decrease of 10ml in absolute 
volume at most.  
 
These studies were performed supine and at rest. The magnitude of ventricular interaction is 
variable; it is likely to decrease on adopting the upright posture as the RV volume decreases, 
and it is likely to increase on exercise, secondary to intestinal venoconstriction (100). Indeed, 
ventricular interaction may be an important mechanism contributing to stroke volume 
limitation and exercise intolerance in CHF (101). The present studies did not examine the 
effect of LV pacing on ventricular interaction during exercise. 
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CONCLUSIONS 
 
In heart failure patients with evidence of external constraint at rest, the acute haemodynamic 
benefits of both BIVP and LVP are principally due to the relief of external constraint and 
preload recruitment. However, in those patients with evidence of electrical dyssynchrony and 
a broad QRS duration, a significant haemodynamic benefit is derived from an enhancement 
in left ventricular contractility, presumably as a result of a reduction in left ventricular 
dyssynchrony. Patients with external constraint may derive a greater haemodynamic benefit 
from pacing due to the significant increase in stroke work that is associated with relief of 
external constraint and preload recruitment, in addition to the increase in stroke work derived 
from enhanced contractility due to a reduction in dyssynchrony.  
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CHAPTER 7  
 
       SUCTION FILLING OF THE LEFT VENTRICLE IN HEART  
                 FAILURE AND THE EFFECT OF CARDIAC  
                        RESYNCHRONISATION THERAPY 
 
INTRODUCTION 
 
A restrictive filling pattern on transmitral inflow, characterised by a steep acceleration and 
deceleration slope of the E wave, is a common feature in patients with advanced heart failure, 
and is known to be an indicator of clinical severity of heart failure. Patients with restrictive 
filling patters are more symptomatic (115-117), have a reduced exercise capacity (118) and 
have an increased risk of death or the need for cardiac transplantation (115;119-122). Our 
previous work has shown that diastolic ventricular interaction (DVI) is common in such 
patients with advanced heart failure, and the presence of a restrictive filling pattern had a high 
sensitivity and specificity for detecting DVI (123). In heart failure the increased filling 
pressures distend the ventricles to such an extent that filling of the left ventricle is impeded 
by the right ventricle and surrounding pericardium. The presence of DVI would explain the 
rapid deceleration of the transmitral E wave. At the onset of diastole, left ventricular volume 
is low and external constraint is minimal, but in late diastole LV filling is impeded by the 
pericardium and right ventricle.  
 
The term ‘suction filling’ has been defined by Katz as the phenomenon whereby the left 
ventricle relaxes faster than it can fill (86), resulting in  a fall in pressure as the left ventricle 
enlarges. Suction filling is therefore the period of filling which occurs during the period of 
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pressure decline to minimum pressure after the mitral valve has opened. We hypothesised 
that an increase in suction filling is responsible for the rapid upstroke of the E wave on 
transmitral inflow in patients with advanced heart failure. 
 
METHODS 
 
Patients. Fifty three patients with chronic heart failure undergoing implantation of a 
biventricular pacemaker were studied who met the following inclusion criteria: NYHA Class 
III/IV symptoms despite maximally tolerated optimal medical therapy; left ventricular 
ejection fraction ≤ 35%; sinus rhythm. Ten patients with structurally normal hearts on 
echocardiography who were undergoing electrophysiology studies for radiofrequency 
ablation for symptomatic supraventricular arrhythmias acted as a control group for 
parameters of suction filling.  
 
Acute Haemodynamic Studies. Acute haemodynamic studies were performed in the 
cardiac catheterisation laboratory at the time of pacemaker implantation with patients in the 
non-sedated and supine state as described in the Methodology in Chapter 2.  
The following parameters were derived from the pressure volume loops (PVL) at baseline 
and during inferior vena cava occlusion: dP/dtMAX, dP/dtMIN, left ventricular end-diastolic 
pressure (LVEDP), pressure at minimum volume (P@Vmin), isovolaemic relaxation time 
(IVRT), Tau, volume of suction filling (SuctVol), volume of non-suction filling (NSuctVol), 
and stroke volume (SV). The volume of suction filling (SuctVol) was defined as the volume 
at minimum pressure (V@Pmin) minus the minimum volume (Vmin), the volume of non-
suction filling as the SV minus SuctVol, and the percentage of suction filling was defined as 
the volume of suction filling divided by the stroke volume (% suction = SuctVol/SV). The 
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isovolaemic relaxation time was defined as the time from end-systole to the time of onset of 
filling (time at which volume increase occurs). The time to minimum pressure (T-Pmin) was 
defined as the time from end-systole to the time at which minimum pressure was reached (see 
Figure 7.1). In addition, the presence or absence of DVI was assessed according to the 
response to inferior vena cava occlusion as described in Chapter 2. 
 
FIGURE 7.1. Representative pressure-volume loop from a patient with chronic heart 
failure 
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Echocardiography. Eleven of the heart failure patients underwent echocardiography 
to compare time intervals related to left ventricular filling with those obtained from the acute 
haemodynamic studies. All studies were performed on a Vivid 7 scanner (GE Ultrasound 
Systems, Horten, Norway) with a 2.5MHz transducer for pulsed wave Doppler recordings. 
These recordings were obtained with the patients lying in a supine position at rest at identical 
heart rates to those during the pressure volume loop studies. Transmitral flow was recorded in 
the standard apical four-chamber view with the sample volume positioned between the tips of 
the mitral leaflets. The isovolaemic relaxation time (IVRT) was derived by subtracting the 
time interval from Peak R-Wave of the ECG to mitral valve opening (onset of E wave) from 
the time interval from Peak R-wave to aortic valve closure. This method incorporating the 
use of the ECG complex eliminates the possibility of measurement error caused by valve 
artifact when measuring small time durations using continuous or pulsed wave Doppler 
imaging. The time interval from the Peak R-Wave of the ECG to the peak of the E wave on 
transmitral flow (T-Peak E) was also measured. The IVRT and T-Peak E time intervals 
derived from echocardiography was compared with the IVRT and T-Pmin derived from the 
pressure volume loops. 
 
Statistical Analysis. All data are expressed as the mean value ± SD. The Mann-
Whitney rank-sum test was used to compare independent samples between the two groups. A 
repeated measure ANOVA was used to assess the effect of vena cava occlusion and pacing if 
the data was normally distributed based on a Kolmogorov-Smirnov test. For data that were 
not normally distributed, a Kruskal-Wallis test was used.  Bland Altman plots were used to 
compare time intervals measured on echocardiography and pressure volume loops. Statistical 
significance was assumed at p < 0.05. 
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RESULTS 
PVL vs. echocardiographic parameters 
There was excellent agreement between echocardiographic Doppler indices and pressure-
volume loop assessments for all parameters. The correlation coefficient between the two 
techniques was r=0.91 for IVRT (Figure 7.2) and r=0.86 for T-Pmin/T-Peak E (Figure 7.3).  
 
FIGURE 7.2A. Bland-Altman plot of echocardiography vs. PVL for IVRT 
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FIGURE 7.2B. Scatter diagram of echocardiography vs. PVL for IVRT  
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FIGURE 7.3A. Bland-Altman plot of echocardiography (T-Peak E) vs. PVL (T-Pmin) 
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FIGURE 7.3B. Scatter diagram of echocardiography (T-Peak E) vs. PVL (T-Pmin)  
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Baseline suction filling parameters from PVL 
Baseline suction filling parameters for both the heart failure and control groups are shown in 
Table 7.1. The percentage of suction filling was significantly higher in the patients with heart 
failure compared with controls (41 ± 23 vs. 17 ± 12%; p<0.01), despite a reduced dP/dtMIN  
(-855 ± 311 vs. -1760 ± 367mmHg/s; p<0.01) and a prolonged Tau (82 ± 17.2 vs. 51.3 ± 14; 
p<0.01). LVEDP was significantly higher in patients compared to controls (18.5 ± 7.6 vs. 8.5 
± 2.9mmHg; p<0.01). IVRT was shorter in the heart failure group (126 ± 27 vs. 146 ± 22ms; 
p=0.03). Baseline suction filling parameters in those patients with and without external 
constraint (EC) at baseline are shown in Table 7.2.  
TABLE 7.1. Baseline suction filling parameters for heart failure and control groups 
 CONTROLS (n=10)  HEART FAILURE (n=53) p value 
 
LVEDP (mmHg) 
 
8.5 ± 2.9 18.5 ± 7.6 p < 0.01†
 
P@ Vmin (mmHg) 
 
10.3 ± 5.9 24 ± 12.1 p < 0.01†
 
IVRT (ms) 
 
146 ± 22 126 ± 27 p = 0.03†
 
Tau 
 
51.3 ± 14 82 ± 17.2 p < 0.01†
 
DP/DTMIN 
 
-1760 ± 367 -834 ± 311 p < 0.01†
 
DP/DTMAX 
 
1391 ± 294 786 ± 204 p < 0.01†
 
Suction volume (ml) 
 
4 ± 4 13 ± 9 p < 0.01†
 
Non-suction volume (ml) 
 
21 ± 12 20 ± 15 p = 0.57 
 
% Suction filling 
 
17 ± 12 41 ± 23 p < 0.01†
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TABLE 7.2. Baseline suction filling parameters for heart failure patients with and 
without external constraint (EC) 
 
    EC (n=30)  NO EC (n=23)       p value 
 
LVEDP (mmHg) 
 
21 ± 5 15 ± 9 p < 0.01† 
 
P@ Vmin (mmHg) 
 
28 ± 10 19 ± 14 p < 0.01† 
 
IVRT (ms) 
 
120 ± 24 136 ± 29 p = 0.05† 
 
Tau 
 
86 ± 16 76 ± 17 p < 0.01† 
 
DP/DTMIN 
 
-753 ± 209 -983 ± 373 p < 0.01† 
 
Suction volume (ml) 
 
14 ± 9 12 ± 9 p = 0.39 
 
Non-suction volume 
(ml) 
 
18 ± 11 22 ± 18 p = 0.79 
 
% Suction filling 
 
44 ± 21 37 ± 25 p = 0.21 
 
 
There was significant correlation between IVRT and % suction filling (correlation 
coefficient=0.50; p < 0.01), between LVEDP and % suction filling (correlation 
coefficient=0.48; p < 0.01), and between P@Vmin and % suction filling (correlation 
coefficient=0.60; p < 0.01). These results are shown in Figures 7.4A, 7.4B, and 7.4C 
respectively.   
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FIGURE 7.4A. Scatter diagram of IVRT and % suction filling 
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p < 0.01† 
FIGURE 7.4B. Scatter diagram of LVEDP and % suction filling 
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p < 0.01† 
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FIGURE 7.4C. Scatter diagram of P@Vmin and % suction filling 
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Changes in suction filling parameters in response to inferior vena cava occlusion (IVCO) 
 
 
Results are shown in Table 7.3. IVCO in the heart failure group resulted in a 41% decrease in 
suction filling (41 ± 23 to 24 ± 17%; p<0.01), a 19% decrease in LVEDP (18.5 ± 7.6 to 14.9 
± 5.6mmHg; p<0.01), and a 33% increase in IVRT (126 ± 27 to 167 ± 37ms; p=0.05).  
 
TABLE 7.3. Suction filling parameters for heart failure group in response to IVCO 
 
  BASELINE IVCO       p value 
 
LVEDP (mmHg) 
 
18.5 ± 7.6 14.9 ± 5.6 p < 0.01† 
 
P@ Vmin (mmHg) 
 
24 ± 12.1 16.8 ± 7.6 p < 0.01† 
 
IVRT (ms) 
 
126 ± 27 167 ± 37 p < 0.05† 
 
Tau 
 
82 ± 17.2 85.2 ± 17.5 p = 0.35 
 
DP/DTMIN 
 
-855 ± 311 -801 ± 207 p = 0.70 
 
Suction volume (ml) 
 
13 ± 9 7 ± 7 p < 0.01† 
 
Non-suction volume (ml) 
 
20 ± 15 22 ± 14 p = 0.26 
 
% Suction filling 
 
41 ± 23 24 ± 17 p < 0.01† 
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Changes in suction filling parameters in response to biventricular pacing (BIVP) 
 
Results are shown in Table 7.4. Biventricular pacing in the heart failure group resulted in a 
37% decrease in suction filling (41 ± 23 to 26 ± 14%; p<0.01) and a 22% increase in IVRT 
(126 ± 27 to 154 ± 28ms; p<0.01). In patients with EC at baseline there was a greater 
reduction in suction filling, LVEDP and P@Vmin, as well as a greater increase in IVRT, as 
shown in Figure 7.4. 
 
TABLE 7.4.  Suction filling parameters for heart failure group in response to BIVP 
 
    BASELINE  BIVP       p value 
 
LVEDP (mmHg) 
 
18.5 ± 7.6 15.7 ± 6.5 p = 0.04† 
 
P@ Vmin (mmHg) 
 
24 ± 12.1 19.9 ± 7.9 p = 0.04† 
 
IVRT (ms) 
 
126 ± 27 154 ± 28 p < 0.01† 
 
Tau 
 
82 ± 17.2 83.2 ± 15.4 p = 0.69 
 
DP/DTMIN 
 
-855 ± 311 -840 ± 296 p = 0.80 
 
DP/DTMAX 
 
786 ± 204 893 ± 219 p = 0.01† 
 
Suction volume (ml) 
 
13 ± 9 10 ± 8 p = 0.09 
 
Non-suction volume (ml) 
 
20 ± 15 27 ± 14 p = 0.02† 
 
% Suction filling 
 
41 ± 23 26 ± 14 p < 0.01† 
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FIGURE 7.4.  Percentage change in suction filling parameters in response to BIVP for 
heart failure patients with (EC) and without external constraint (NO EC) 
 % change 
 
† 
† 
† 
 
 Indicates significant difference between EC and NO EC group (p < 0.05)  † 
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DISCUSSION 
 
 
In the present study we have demonstrated a significant increase in the percentage of suction 
filling (the percentage of total filling occurring during the period in which the left ventricular 
pressure is falling) in patients with advanced heart failure compared with patients with a 
structurally and functionally normal heart.  
 
At baseline we found an excellent correlation between timing intervals on echocardiography 
and pressure-volume loop analysis, confirming that filling of the left ventricle was occurring 
during a period of ongoing left ventricular relaxation and pressure decline. Despite a marked 
slowing of active relaxation of the left ventricle in the heart failure group at baseline, as 
evidenced by a reduction in dp/dtMIN and a prolonged Tau, the percentage of suction filling 
was markedly increased.  
 
This increase in suction filling was associated with a higher LVEDP, a shorter IVRT, and an 
onset of left ventricular filling and volume increase at a higher pressure (P@Vmin). A 
significant correlation was demonstrated at baseline between these three variables and the 
percentage suction filling, with the strongest association being between P@Vmin and % 
suction filling. Despite the slower rate of active relaxation of the left ventricle, the shorter 
IVRT is associated with an earlier opening of the mitral valve at a higher pressure. Filling 
therefore occurs during a period of ongoing pressure decline as ventricular relaxation is 
prolonged, as demonstrated in the schematic in Figure 7.5. 
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FIGURE 7.5.  Effects of slowing of the rate of active LV relaxation and increase LVEDP 
on suction filling in heart failure  ∆ Pressure 
 
Control      Heart Failure 
 Time 
This is consistent with data from Wang et al, who have utilised wave intensity analysis in a 
canine animal model to assess left ventricular diastolic suction(124). They demonstrated that 
the relaxing left ventricle generates an expansion wave that first decelerates the stroke 
volume moving through the aorta, then rapidly declines in magnitude during isovolaemic 
relaxation, and finally accelerates blood in the mitral inflow tract. The total energy of that 
expansion wave and the energy remaining after mitral valve opening were shown to be 
inversely related to the rate of decline of LV pressure (i.e. Tau), but also inversely related to 
the completeness of left ventricular emptying or LVESV (left ventricular end-systolic 
volume). This suggests that although total energy expenditure may be reduced in heart failure 
a greater proportion of that energy expenditure occurs when the mitral valve is open and 
filling is occurring due to a prolongation of active relaxation. They too demonstrated an 
association between the size of the diastolic suction wave and the size of the E wave of early 
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transmitral filling, suggesting that the left ventricular diastolic suction wave is more 
important than the passive decompression of the left atrium in determining the size of the E 
wave.  
 
However, Yotti et al have shown conflicting results utilising a non-invasive 
echocardiographic method of assessment of diastolic suction in patients with a dilated 
cardiomyopathy(125). Using colour M-mode Doppler they measured intraventricular 
diastolic pressure differences (DIVPD) from the apex to base, and demonstrated a significant 
reduction in total DIPVD in patients with DCM compared with healthy controls. Two types 
of DIVPD exist, and together contribute to the total DIVPD. Inertial DIVPD, as a result of 
inertial acceleration of blood, is responsible for generating a favourable suction force 
(pressure drop from base to apex) to accommodate the filling volume received from the left 
atrium. In contrast, the convective DIPVD results in deceleration of blood flow (pressure rise 
from base to apex) in opposition to flow. However, despite the overall decrease in total 
DIVPD in the DCM group as a whole, it is interesting to note that the patients group who had 
evidence of a restrictive mitral inflow pattern had an increase in inertial component and a 
reduction in the convective component of the total DIVPD in comparison to the patients 
without evidence of a restrictive filling pattern on baseline echocardiography. This suggests 
that patients with a restrictive filling physiology may indeed generate a greater diastolic 
suction wave than those with non-restrictive filling. 
 
Preload reduction accomplished by inferior vena cava occlusion resulted in a significant 
reduction in the percentage of suction filling in the heart failure patients, accompanied by a 
significant reduction in LVEDP and P@Vmin, and a significant increase in IVRT (a 
consequence of delayed mitral valve opening due to a reduction in left atrial pressure as a 
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result of preload reduction). This was demonstrated despite no significant change in 
parameters of active LV relaxation (Tau and dp/dtMIN).  
 
In the present study biventricular pacing (BIVP) has been shown to have a significant effect 
on the percentage of left ventricular diastolic suction filling. As previously demonstrated by 
Turner et al (25), BIVP resulted in a significant reduction in both LVEDP and in P@Vmin, 
associated with a significant lengthening of the IVRT, indicating that mitral valve opening 
was occurring later. As previously demonstrated by ourselves (102), BIVP resulted in a 
significant improvement in dp/dtMAX, but had no acute effect on the rate of active LV 
relaxation (as evidenced by an unchanged dp/dtMIN and Tau). The significant reduction seen 
in the percentage of suction filling is a due to both a reduction in the volume of suction filling 
(as a result of delayed mitral valve opening and a longer IVRT) and a significant increase in 
the non-suction filling volume as a result of an increased stroke volume. This increase in 
stroke volume occurs as a result in increased contractility (significant increase in dp/dtMAX) 
and an improvement in absolute left ventricular stroke work and preload recruitable stroke 
work (in part due to a relief of external constraint) in response to BIVP, as previously 
demonstrated by ourselves(102).  
 
STUDY LIMITATIONS 
 
The calibration method of the conductance catheter was not based on assessment of absolute 
volume, but this would not affect results, which depend entirely on relative changes within 
each patient in response to the pacing mode.  
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Assessment of left ventricular diastolic suction was based entirely on the volume of filling 
occurring during the period of left ventricular pressure decline, but did not involve the 
assessment of pressure gradients from the left ventricular base to apex. 
 
 
CONCLUSIONS 
 
In the present study we have demonstrated a significant increase in the percentage of suction 
filling (the percentage of total filling occurring during the period in which the left ventricular 
pressure is falling) in patients with advanced heart failure compared with patients with a 
structurally and functionally normal heart. Biventricular pacing (BIVP) has been shown to 
have a significant effect on the percentage of left ventricular diastolic suction filling. BIVP 
resulted in a significant reduction in both LVEDP and in P@Vmin, associated with a 
significant lengthening of the IVRT, indicating that mitral valve opening was occurring later. 
The significant reduction seen in the percentage of suction filling is due to both a reduction in 
the volume of suction filling and an increase in the non-suction filling volume as a result of 
an increased stroke volume. 
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  CHAPTER 8  
 
 
           DISCUSSION, CONCLUSIONS, AND FUTURE STUDIES 
 
The introductory chapters of this thesis outline the development of the role of cardiac pacing 
in patients with heart failure and describe the initial studies that guided the rationale for 
cardiac resynchronisation therapy, and subsequent patient selection. To date several 
randomised controlled studies have shown CRT to be effective in improving quality of life 
and exercise capacity, in addition to resulting in left ventricular reverse modeling. Most 
importantly, CRT has been shown to result in a reduction in morbidity and mortality. The 
mechanism by which CRT improves cardiac performance has always been thought to be 
primarily due to electrical and mechanical resynchronisation, with a reduction in mitral 
regurgitation occurring as a result of papillary muscle resynchronisation acutely and left 
ventricular reverse remodelling chronically. Recently, an additional mechanism for benefit 
has been demonstrated, in the form of relief of diastolic ventricular interaction and external 
constraint to left ventricular filling. 
 
However, despite the wealth of data showing a benefit for CRT in refractory heart failure, 
several questions still remain regarding optimal patient selection and the exact mechanisms 
by which CRT improves cardiac function. These questions have been driven by the fact that 
up to 30% of patients who meet current clinical criteria for implantation of CRT fail to 
demonstrate a subjective or objective improvement in cardiac status.  
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The demonstration of a weak correlation between electrical (electrocardiographic) 
dyssynchrony, as evidenced by the duration of the QRS complex on surface ECG, and 
mechanical dyssynchrony has resulted in significant interest in the use of CRT in patients 
with a narrow QRS duration, with early small studies suggesting a benefit.  
 
In addition, the question of optimal pacing mode and programming of particular atrio-
ventricular and inter-ventricular timing intervals has led to studies assessing the effects of 
simultaneous biventricular pacing and left ventricular pacing only. 
 
The principal objectives of the work presented in this thesis were to investigate whether 
cardiac resynchronisation therapy in patients with a narrow QRS duration would result in 
similar acute haemodynamic benefits to those seen in patients with a broad QRS duration. In 
addition, the mechanisms by which pacing improves cardiac performance were assessed in 
patients with both narrow and broad QRS duration, with a particular interest in defining the 
optimal pacing mode in patients with and without evidence of external constraint. These 
findings will aim to better inform patient selection and allow optimisation of pacing strategy 
in individual patients. 
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 SUMMARY OF RESULTS 
 
1. Cardiac resynchronisation therapy results in significant acute haemodynamic benefits 
in patients with heart failure, a narrow QRS duration, and no evidence of mechanical 
dyssynchrony on echocardiography. These acute haemodynamic benefits are 
comparable to those demonstrated in patients with a broad QRS duration in both the 
present study and from previously published data. These findings indicate that the 
benefit from cardiac resynchronisation therapy is not only related to 
resynchronisation, but that additional mechanisms are responsible for the benefit 
derived from pacing.  
 
2. External constraint to left ventricular filling was present in 50% of patients regardless 
of baseline QRS duration. Both biventricular and left ventricular pacing were 
effective at significantly reducing the magnitude of external constraint in conjunction 
with an increase in left ventricular end-diastolic volume, allowing for preload 
recruitment and an increase in left ventricular stroke work via utilization of the 
Starling mechanism.  
 
 
3. In patients with heart failure and severe left ventricular dysfunction, right ventricular 
pacing resulted in acute haemodynamic deterioration. The optimal interventricular 
timing delay can be predicted based on the presence or absence of external constraint 
at baseline. In those patients with external constraint, interventricular delays with the 
left ventricle being the first chamber paced resulted in a trend towards greater increase 
in left ventricular stroke work, whereas in patients without external constraint near-
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simultaneous interventricular timing intervals appeared beneficial. These results 
indicate that patients with external constraint benefit from a greater phase shift in the 
timing of left ventricular events relative to right ventricular events, allowing the left 
ventricle to fill at a time when the right ventricular volume and pressure are lower. 
 
4. The acute haemodynamic benefits of both biventricular and left ventricular pacing are 
principally due to a reduction in external constraint and preload recruitment, 
accounting for two-thirds of the absolute gain in left ventricular stroke work with 
pacing. Patients with external constraint demonstrated a greater haemodynamic 
benefit from pacing than those without due to preload recruitment in addition to the 
gain in stroke work from enhanced contractility. 
 
 
5. In patients with a narrow QRS duration, preload recruitment accounted for 70% of the 
benefit from pacing, whereas in patients with a broad QRS duration, the contributions 
from preload recruitment and enhanced contractility were equivalent. This suggests 
that in patients without evidence of mechanical or electrical dyssynchrony, the benefit 
derived from resynchronisation may still be significant. 
 
6. In patients with heart failure there is a significant increase in the percentage of suction 
filling, defined as filling occurring after mitral valve opening during a period of 
ongoing pressure decline to a minimum value. This increase in the percentage of 
suction filling correlated significantly with a higher LVEDP, a shorter isovolaemic 
relaxation time, and a higher pressure at the onset of left ventricular filling 
(P@Vmin). This suggests that although active relaxation in heart failure is prolonged, 
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a greater proportion of the total energy expenditure involved in LV relaxation occurs 
when the mitral valve is open at a time when left ventricular pressure is declining. 
 
 
 
DISCUSSION 
 
Although a significant number of patients with medically-refractory heart failure have 
benefitted from cardiac resynchronisation therapy, there remains a significant non-responder 
rate. Based on the initial rationale that pacing therapy improved cardiac function via a 
reduction in inter- and intra-ventricular dyssynchrony, current guidelines require the presence 
of electrical dyssynchrony (with or without mechanical dyssynchrony) in order to qualify for 
device therapy. However, it is accepted that electrical dyssynchrony (as evidenced by a 
prolonged QRS duration) is not synonymous with mechanical dyssynchrony, and in fact 
significant dyssynchrony may be demonstrated on echocardiography in patients with a 
narrow QRS duration. In addition, recent studies such as PROSPECT have cast doubt on the 
current echocardiographic methods used to assess the presence of dyssynchrony. The high 
rate of non-response to CRT suggests that a better understanding of the mechanism by which 
CRT improves cardiac function is required in order to best target those patients likely to 
derive a benefit from device therapy. 
 
The current body of work highlights the limitations in the current guidelines, demonstrating 
an equivalent haemodynamic benefit from CRT in those patients with neither electrical nor 
mechanical dyssynchrony, a group currently excluded from receiving device therapy in the 
United Kingdom. Several small, randomised studies have demonstrated a beneficial effect 
from CRT in patients with a narrow QRS and evidence of mechanical dyssynchrony on 
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echocardiography, but this is the first study to demonstrate comparable haemodynamic 
benefits to those seen in heart failure patients with dyssynchrony. Whether this will translate 
into long-term symptomatic improvements with a reduction in morbidity and mortality has 
yet to be determined, but highlights the need for large, randomised controlled trials in this 
patient group. 
 
Although the traditional view has been that CRT exerts its beneficial effect via a reduction in 
both inter- and intra-ventricular dyssynchrony, these data suggests that preload recruitment 
via the relief of external constraint is a significant mechanism resulting in improvements in 
left ventricular stroke work. In fact, in patients with evidence of external constraint at rest 
(accounting for half of the patients), the predominant mechanism resulting in improvement in 
cardiac function was the relief of external constraint, allowing preload recruitment and an 
increase in left ventricular stroke work via recruitment of the Starling mechanism. This effect 
was more pronounced in patients without evidence of mechanical or electrical dyssynchrony, 
but even in the patients with dyssynchrony this mechanism accounted for 50% of the 
improvement demonstrated in left ventricular stroke work. In addition, the fact that patients 
with external constraint demonstrated a greater haemodynamic benefit from CRT suggests 
that an assessment for the evidence of diastolic ventricular interaction on echocardiography 
may help to predict which patients are more likely to respond to pacing. 
 
At present, the current practice amongst many physicians is to program the CRT at implant to 
default manufacturer settings (most commonly providing simultaneous biventricular 
stimulation with a short atrio-ventricular delay), with a view to an attempt at optimisation of 
atrioventricular and interventricular timings only in non-responders. Although a significant 
numbers of patients will respond favourably to these default settings, there is an argument for 
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predicting the optimal pacing strategy from the pre-implant echocardiography and 
haemodynamic indices at implant.  
Patients with a restrictive filling pattern and a high LVEDP are very likely to have external 
constraint to left ventricular filling, and based on our current data would derive a greater 
haemodynamic benefit from a pacing strategy in which the left ventricle is activated 
significantly earlier than the right (or even left ventricular only pacing). In patients without 
external constraint and a low LVEDP it would appear reasonable to program simultaneous 
biventricular stimulation initially, with a view to reprogramming to left ventricular pre-
excitation in non-responders.  
 
Patients with external constraint derive a greater haemodynamic benefit from pacing, with the 
stroke work gain from preload recruitment accounting for around two-thirds of the benefit 
achieved with both biventricular and left ventricular pacing. In the present study we used an 
invasive measure of the presence or absence of external constraint, namely inferior vena 
caval occlusion and left heart catheterisation. However, this method of assessment is not 
feasible in all heart failure patients. Similarly, assessing the change in left ventricular end-
diastolic volume in response to the application of lower body negative pressure to assess for 
external constraint remains a research tool and not widely clinically available.  
 
Echocardiography provides the simplest and easily accessible method for assessing the 
volume and pressure of the right ventricle, right atrial pressure (an excellent surrogate for 
pericardial pressure), septal position, septal motion, and the transmitral filling pattern. As 
previously described, the presence of a restrictive transmitral filling pattern has both a high 
sensitivity and specificity for detecting diastolic ventricular interaction and external 
constraint (123).  
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 In addition, the position of the interventricular septum at end-diastole provides valuable 
information relating to the trans-septal pressure gradient (LVEDP minus RVEDP). The 
normal interventricular septum is convex when viewed from the left ventricle, with the shape 
remaining the same in systole and diastole because the pressure in the left ventricle remains 
higher than in the right. The impact of right ventricular volume or pressure overload can lead 
to a reversal of the end-diastolic trans-septal pressure gradient, resulting in the septum 
becoming flattened or even concave at end-diastole (often in association with paradoxical 
septal motion as the septum moves rightward during systole as a result of restoration of the 
normal positive trans-septal pressure gradient). This is often seen as a delay in septal to 
posterior wall contraction on M-mode echocardiography of > 130ms. The echocardiographic 
assessment of ventricular interdependence could easily be incorporated into current protocols, 
in addition to non-invasive assessment of LVEDP using the E/E’ ratio (transmitral E wave 
velocity / tissue Doppler E velocity derived at the mitral valve annulus), in order to identify 
patients more likely to derive a significant benefit from pacing. 
 
Although initial work is necessary to better predict those patients most likely to respond to 
pacing, this study gives significant insight into the mechanisms of benefit derived from 
pacing, as well as clues to the optimal pacing strategy in individual patients. However, 
several questions arise which can be answered with future studies, as described below. 
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 FUTURE STUDIES 
 
(1) Assessment of the magnitude of external constraint on exercise 
Although only 50% of patients with congestive heart failure have evidence of external 
constraint at rest, it is likely that it develops in most patients during exercise (and 
contributes significantly to the exercise limitation demonstrated in this group of 
patients). External constraint may help to explain why exercise tolerance is limited in 
patients with heart failure, since it prevents utilisation of the Starling mechanism to 
increase cardiac output as previously discussed). 
Although it is not feasible to assess the magnitude of external constraint on exercise 
via pressure-volume loop analysis, it is possible to assess for the presence or absence 
of external constraint non-invasively using radionuclide ventriculography. In patients 
with heart failure, both LVEDP and RVEDP become elevated on exercise. If external 
constraint is present on exercise, the increase in RVEDP and RVEDV will result in 
significant diastolic ventricular interaction and external constraint to the left 
ventricular filling. In addition, a rise in pericardial pressure (as a result on the J-
shaped stress-strain relationship of the pericardium) will occur, resulting in significant 
pericardial constraint. The combined effects will effectively restrain left ventricular 
filling, resulting in a decrease in LVEDV and subsequent reduction in left ventricular 
stroke volume. The change in RVEDV, LVEDV, and left ventricular stroke volume 
can be assessed using radionuclide ventriculography performed at rest and 
subsequently on exercise using supine cycle ergometry.  
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(2) Assessment of the safety and efficacy of long-term resynchronisation therapy utilising 
a left ventricular pacing strategy 
Although left ventricular pacing has been shown to produce equivalent if not superior 
acute haemodynamic benefits compared with biventricular pacing, there is 
understandably still some hesitation from clinicians regarding the use of cardiac 
stimulation from a left ventricular electrode only. Left ventricular pacing electrodes 
are known to have a higher rate of displacement in part due to the extreme variability 
of the venous anatomy of the coronary sinus and in part due to the lack of a reliable 
active fixation method for these leads. There is some concern that a left ventricular 
based pacing strategy may lead to lead to issues with consistent capture and pacing.  
 
In order to assess the safety of long-term left ventricular pacing it will be necessary to 
perform a randomised controlled crossover trial of left ventricular versus biventricular 
pacing to assess the safety of such a pacing strategy and to compare the percentage of 
pacing achieved with both pacing modes. The effect of pacing mode on quality of life, 
exercise capacity, left ventricular reverse remodelling, and symptomatic status will 
also be assessed. 
 
(3) Assessment of the feasibility and efficacy of a mode-switch algorithm in cardiac 
resynchronisation devices to left ventricular pacing 
As previously described, although only half of all heart failure patients have evidence 
of external constraint and diastolic ventricular interaction at rest, it is likely that many 
more will develop it with exercise. It is also likely that patients will develop 
significant external constraint from both the right ventricle and the lungs during acute 
decompensations of heart failure associated clinically with fluid retention.  
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As we have demonstrated in the current work, patients with external constraint derive 
a greater haemodynamic benefit from cardiac resynchronisation therapy than those 
without, with a trend towards a greater benefit from left ventricular pacing. The ideal 
pacemaker would incorporate a mode-switch algorithm allowing a switch from 
biventricular to left ventricular pacing triggered either by exercise, or by changes in 
thoracic impedance, allowing a left ventricular-based pacing strategy to be used in 
situation where significant external constraint is likely to develop. 
 
 
CONCLUSIONS 
This thesis provides new evidence for the acute haemodynamic benefit of cardiac 
resynchronisation therapy in patients with medically-refractory heart failure and a narrow 
QRS duration. Indeed these improvements in haemodynamic variables are comparable to 
those demonstrated in patients with a broad QRS duration, and suggests that current criteria 
for implantation of these devices may exclude a group of patients who may be expected to 
experience significant clinical benefit from pacing. In addition, it emphasizes the role of 
relief of external constraint in contributing to the increase in left ventricular stroke work, 
suggesting that this group of patients may be expected to benefit the most.  
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